@prefix : <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl> .
@prefix mp: <http://purl.org/mp/> .
@prefix oa#: <http://www.w3.org/ns/oa#> .
@prefix opv: <http://inab.certh.gr/OpenPVSignal> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix openpvsignal: <http://purl.org/OpenPVSignal/OpenPVSignal.owl> .
@base <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl> .

<http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl> rdf:type owl:Ontology ;
                                                                                              owl:imports <http://purl.org/OpenPVSignal/OpenPVSignal.owl> ,
                                                                                                          mp: ;
                                                                                              rdfs:isDefinedBy "https://apps.who.int/iris/handle/10665/272295/"^^xsd:anyURI ;
                                                                                              rdfs:label "Ciprofloxacin, enalapril and acute kidney injury: strengthening of a drug interaction signal"^^rdfs:Literal ;
                                                                                              owl:versionInfo "draft-v0.95-20211007"@en .

#################################################################
#    Annotation properties
#################################################################

###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code
<http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> rdf:type owl:AnnotationProperty .


###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code
<http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> rdf:type owl:AnnotationProperty .


###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code
<http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> rdf:type owl:AnnotationProperty .


###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term
<http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> rdf:type owl:AnnotationProperty .


#################################################################
#    Datatypes
#################################################################

###  http://www.w3.org/2001/XMLSchema#date
xsd:date rdf:type rdfs:Datatype .


#################################################################
#    Object Properties
#################################################################

###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element
<http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element> rdf:type owl:ObjectProperty .


###  http://purl.org/mp/publishedBy
mp:publishedBy rdf:type owl:ObjectProperty .


###  http://purl.org/mp/references
mp:references rdf:type owl:ObjectProperty .


#################################################################
#    Classes
#################################################################

###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#introduction
:introduction rdf:type owl:Class .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#summary
:summary rdf:type owl:Class .


#################################################################
#    Individuals
#################################################################

###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#Introduction
<http://purl.org/OpenPVSignal/OpenPVSignal.owl#Introduction> rdf:type owl:NamedIndividual ,
                                                                      :introduction .


###  http://purl.org/OpenPVSignal/OpenPVSignal.owl#Summary
<http://purl.org/OpenPVSignal/OpenPVSignal.owl#Summary> rdf:type owl:NamedIndividual ,
                                                                 :summary .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ACE_inhibitors
:ACE_inhibitors rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#DrugClass> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C09A" ;
                rdfs:label "ACE inhibitors" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#AKI_pathophysiology
:AKI_pathophysiology rdf:type owl:NamedIndividual ,
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element> ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "A range of pre-renal, renal and post-renal clinical conditions can lead to AKI. Drugs can be involved at any of these levels and so may cause conditions leading to pre-renal injury by volume depletion e.g. through haemorrhage or dehydration, or through a direct effect on glomerular arteriolar pressures. Drug-induced direct renal toxicity e.g. due to interstitial nephritis or acute tubular necrosis is well-recognised. Promotion of renal stone formation can lead to post-renal obstruction and AKI." ;
                     rdfs:label "AKI pathophysiology" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Bronchitis
:Bronchitis rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "J40" ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10006451 ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Bronchitis" ;
            rdfs:label "bronchitis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#CIForCiprofloxacinAndAKI
:CIForCiprofloxacinAndAKI rdf:type owl:NamedIndividual ,
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Confidence_interval_0.95> ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_lower_limit> 2.03 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_upper_limit> 3.76 ;
                          rdfs:label "CI for ciprofloxacin and AKI" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#CIForFluorquinolonesAndAKI
:CIForFluorquinolonesAndAKI rdf:type owl:NamedIndividual ,
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Confidence_interval_0.95> ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_class> :fluroquinolones ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_lower_limit> 1.74 ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_upper_limit> 2.73 ;
                            rdfs:label "CI for fluorquinolones and AKI" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#CIForrenin-angiotensinSystemBlockersAndAKI
:CIForrenin-angiotensinSystemBlockersAndAKI rdf:type owl:NamedIndividual ,
                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Confidence_interval_0.95> ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_class> :ACE_inhibitors ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_lower_limit> 0.84 ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_upper_limit> 1.18 ;
                                            rdfs:label "CI for renin-angiotensin system blockers and AKI" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#CIForrenin-angiotensinSystemBlockersCombinedWithCiprofloxacinAndAKI
:CIForrenin-angiotensinSystemBlockersCombinedWithCiprofloxacinAndAKI rdf:type owl:NamedIndividual ,
                                                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Confidence_interval_0.95> ;
                                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_class> :ACE_inhibitors ;
                                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_lower_limit> 2.84 ;
                                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_upper_limit> 6.99 ;
                                                                     rdfs:label "CI for renin-angiotensin system blockers combined with ciprofloxacin and AKI" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Ciprofloxacin_and_enalapril_triggering_acute_kidney_injury
:Ciprofloxacin_and_enalapril_triggering_acute_kidney_injury rdf:type owl:NamedIndividual ,
                                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Structured_Product_Labels_information> ;
                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ,
                                                                                                                           :enalapril ;
                                                            mp:references :Ref.3 ,
                                                                          :Ref.6 ,
                                                                          :Ref.7 ,
                                                                          :Ref.8 ;
                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "The United Kingdom summary of product characteristics and US Food and Drug Administration (FDA) labels for enalapril (Innovace®, Vasotec®) and ciprofloxacin (Cipro®) do not list the two substances as interacting" ;
                                                            rdfs:label "UK SMPC for Ciprofloxacin and enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#CommentsOnReport10
:CommentsOnReport10 rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Renal artery stenosis on Doppler ECHO but arteriography normal" ;
                    rdfs:label "Comments on Report 10" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#CommentsOnReport12
:CommentsOnReport12 rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient12 ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Conflicting information for ciprofloxacin discontinuation" ,
                                                                                "Sitagliptin and enalapril discontinued and vessel resection, no improvement. Dronedarone discontinued, recovering." ;
                    rdfs:label "Comments on Report 12" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#CommentsOnReport14
:CommentsOnReport14 rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Leucopenia after telavancin and cefepime, then pancytopenia after all other antibiotics" ;
                    rdfs:label "Comments on Report 14" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#CommentsOnReport15
:CommentsOnReport15 rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Ramucirumab one month prior. Infection during chemotherapy. AKI and rash after start antibiotics." ;
                    rdfs:label "Comments on Report 15" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#CommentsOnReport2
:CommentsOnReport2 rdf:type owl:NamedIndividual ,
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Profuse diarrhoea 2 days after starting ciprofloxacin" ;
                   rdfs:label "Comments on Report 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#CommentsOnReport3
:CommentsOnReport3 rdf:type owl:NamedIndividual ,
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Abdominal sonography normal" ;
                   rdfs:label "Comments on Report 3" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#CommentsOnReport8
:CommentsOnReport8 rdf:type owl:NamedIndividual ,
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Renal CT and ultrasound scan normal" ;
                   rdfs:label "Comments on Report 8" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#CommentsOnReport9
:CommentsOnReport9 rdf:type owl:NamedIndividual ,
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Case_Report_Information> ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Died due to cardiac failure 8 days after medicines were discontinued" ;
                   rdfs:label "Comments on Report 9" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Discussion_and_Conclusion
:Discussion_and_Conclusion rdf:type owl:NamedIndividual ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Conclusion> ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Discussion> ;
                           mp:references :Ref.1 ,
                                         :Ref.2 ,
                                         :Ref.7 ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """The VigiBase case reports describe AKI occurring soon after ciprofloxacin was prescribed in patients taking enalapril. This adverse effect could be attributable to ciprofloxacin alone or to infection. However, three observations suggest a combined effect. Firstly, the increased disproportionality measure (Ω025 >0) for the enalapril/ ciprofloxacin/AKI combination compared with the background data in VigiBase. Secondly, an independent nested case control study showed a greater than additive risk of AKI with coprescribed fluoroquinolones and renin angiotensin blockers.1 Thirdly, in the VigiBase reports a high proportion of patients were at risk of AKI including ACE inhibitor adverse renal effects, but AKI did not occur until ciprofloxacin was added. While the contributing reports to the other combi- nations in Table 2 need more clinical assessment, the disproportionality measures suggest that infection and antibiotic-related diarrhoea do not completely explain the observations. In addition, the case-control study1 suggested that urinary tract infection indications for ciprofloxacin were also unlikely to be an explanation. The disproportionality estimates in Table 2 do support a class effect of ACE inhibitors with ciprofloxacin. A potential mechanism for the observed interaction has not been identified. Most of the published reports summarised by Lomaestro indicate acute interstitial nephritis as the underlying cause of AKI with fluoroquinolones.2 This is rare although the estimated incidence of 1 in 1,526 in the case control study of hospital admissions is likely to be an underestimate as patients may have been admitted with an alternative primary diagnosis or recovered before needing admission. Interstitial nephritis or other pathology due to a fluoroquinolone could be a trigger for ACE inhibitor-related AKI or more severe AKI leading to admission. There were no pathological descriptions in the VigiBase reports. The case control study included only men as it was nested in a cohort study of the health of men aged 40 to 85 years.1 The VigiBase case series included both males and females and the age range was similar or older. It included patients with risk factors for acute renal failure and risk factors for ACE inhibitor-related renal failure. It could be argued that these are sufficient in themselves to explain the AKI, but the addition of ciprofloxacin just prior to onset of AKI suggests that it may have had a causal or contributory role. Also the increased risks of
AKI for fluoroquinolones with and without renin angiotensin blockers in the case-control study were estimated after adjusting for many of these risk factors. At least half of the patients in the VigiBase series received ciprofloxacin together with enalapril in an ambulatory setting. This is also likely in the casecontrol study as the case patients were those admitted because of AKI. Therefore, co-prescription of enalapril and ciprofloxacin may not be uncommon in primary care. The US FDA has recently issued advice against using ciprofloxacin for specified urinary and respiratory infections, unless there are no alternatives, because of serious non-renal toxicities.7 The observations in the VigiBase reports and case-control study1 therefore need further investigation to ascertain if it is advisable to extend the advice to ciprofloxacin use with an ACE inhibitor because of an additional risk of nephrotoxicity in vulnerable patients. The VigiBase reports also provide insights into the prescribing of ACE inhibitors and reiterate the need for careful consideration of age, renal function, hydration status and concomitant prescribing of diuretics or NSAIDs, and for monitoring throughout treatment for changes in clinical status that might increase the risk of renal impairment.""" ;
                           rdfs:label "Discussion and Conclusion" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Dr_Ruth_Savage
:Dr_Ruth_Savage rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Author> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_affiliation> "Upsalla Monitoring Centre" ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_first_name> "Ruth" ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_last_name> "Savage" ;
                rdfs:label "Dr Ruth Savage" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Literature_and_Labelling
:Literature_and_Labelling rdf:type owl:NamedIndividual ,
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Literature_information> ;
                          mp:references :Ref.1 ,
                                        :Ref.2 ,
                                        :Ref.3 ,
                                        :Ref.6 ,
                                        :Ref.7 ,
                                        :Ref.8 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "The United Kingdom summary of product characteristics and US Food and Drug Administration (FDA) labels for enalapril (Innovace®, Vasotec®) and ciprofloxacin (Cipro®) do not list the two substances as interacting.3,6,7,8 These labels reiterate the information about renal dysfunction with each of these medicines, described in the Introduction. Lomaestro2 conducted a literature review to ascertain the incidence and characteristics of fluoroquinolone-related nephrotoxicity. Publications were mostly case reports and the incidence was difficult to estimate. Nearly all of the 44 reports of acute renal failure identified involved patients aged over 50 years. The most frequently reported pathology was acute interstitial nephritis. A high proportion of patients were taking other nephrotoxic medicines, particularly chemotherapeutic and immunosuppressive agents. One patient was taking an ACE inhibitor. A nested case-control study examined the risk of AKI with the use of fluoroquinolones in a cohort of men aged between 40 and 85 years in the US IMS Lifelink Heath Plan Claims Database.1 The number of cases and controls was 1,292 and 12,651 respectively. After adjusting for fluoroquinolone indication, which included genitourinary infections, diseases associated with AKI including congestive heart failure and diabetes, and potentially nephrotoxic medicines with high use i.e. NSAIDs, loop diuretics and renin-angiotensin blockers, the rate ratio (RR) of AKI with current fluoroquinolone use was 2.18 (95% confidence interval (CI) 1.74 – 2.73), which equated to an absolute increase in AKI of 6.5/10,000 person-years or one additional case per 1,529 patients given a fluoroquinolone. This finding was supported by the results of a case-timecontrol analysis in the same cohort in which withinpatient comparisons were made of drug exposures. The findings were similar whether or not patients had genitourinary infection or chronic kidney disease. The highest RR for the individual fluoroquinolones was for ciprofloxacin (2.76, 95% CI 2.03 – 3.76). This increased risk was not found with amoxicillin and azithromycin suggesting infection was not an alternative explanation. The authors also hypothesised interactions between fluoroquinolones and NSAIDs, loop diuretics or renin-angiotensin system blockers (ACE inhibitors or angiotensin-receptor blockers) but only had sufficient power to examine the renin-angiotensin system blockers. There was no increase in risk of AKI with renin-angiotensin system blocker treatment alone (RR 1.00, 95% CI 0.84 – 1.18) but the combined use of these medicines with fluoroquinolones increased the RR for AKI from 2.18 for fluoroquinolones alone to 4.46 (95% CI 2.84 – 6.99) which was greater than the additive risk. The lack of increased risk of AKI with reninangiotensin system blockers alone was unexpected. The authors considered that physician monitoring of serum creatinine levels, particularly after starting renin-angiotensin blockers may be one explanation." ;
                          rdfs:label "Literature and Labelling" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Mechanism_of_Ciprofloxacin
:Mechanism_of_Ciprofloxacin rdf:type owl:NamedIndividual ,
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Mechanism> ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_part_of> :introduction ;
                            mp:references :Ref.1 ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Ciprofloxacin is a broad spectrum fluoroquinolone antibiotic." ;
                            rdfs:label "Mechanism of Ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Mechanism_of_Enalapril
:Mechanism_of_Enalapril rdf:type owl:NamedIndividual ,
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Mechanism> ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_part_of> :introduction ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Enalapril is an angiotensin converting enzyme (ACE) inhibitor used to reduce blood pressure and treat cardiac failure. ACE inhibitors decrease the production of angiotensin II, a substance which causes post-glomerular arteriolar constriction thus maintaining glomerular capillary filtration." ;
                        rdfs:label "Mechanism of Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Mechanism_of_renal_toxicity
:Mechanism_of_renal_toxicity rdf:type owl:NamedIndividual ,
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect_Mechanism> ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :renal_failure ;
                             mp:references :Ref.4 ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "ACE inhibitors decrease the production of angiotensin II, a substance which causes post-glomerular arteriolar constriction thus maintaining glomerular capillary filtration. Usually pre-glomerular arteriolar pressures are high enough for adequate filtration in the presence of ACE inhibition but drugs and clinical conditions that affect renal blood flow and pre-glomerular arteriolar pressures may trigger renal failure in patients taking ACE inhibitors These include concomitant use of loop, thiazide or potassium-sparing diuretics, and prostaglandin inhibitors (NSAIDs), renal artery stenosis, renal transplant, old age, ischaemic heart disease and congestive heart failure, sodium restriction, sodium depletion, volume depletion, hypotension and gastrointestinal fluid loss.4" ;
                             rdfs:label "Mechanism of enalapril and renal toxicity" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#NSAIDS
:NSAIDS rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#DrugClass> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N02BE" ;
        rdfs:label "NSAIDS" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#OmeegaValueForEnalaprilAndAzithromycin
:OmeegaValueForEnalaprilAndAzithromycin rdf:type owl:NamedIndividual ,
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :azithromycin ,
                                                                                                       :enalapril ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_expected_count> "6.9"^^xsd:float ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 0.65 ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_number_of_reports> 11 ;
                                        rdfs:label "Omega value for Enalapril and Azithromycin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Omega025ForEnalaprilAndAzithromycin
:Omega025ForEnalaprilAndAzithromycin rdf:type owl:NamedIndividual ,
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :azithromycin ,
                                                                                                    :enalapril ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> -0.33 ;
                                     rdfs:label "Omega025 value for Enalapril and Azithromycin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Omega025ValueForCiprofloxacinAndEnalapril1
:Omega025ValueForCiprofloxacinAndEnalapril1 rdf:type owl:NamedIndividual ,
                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ,
                                                                                                           :enalapril ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 1.56 ;
                                            rdfs:label "Omega025 value for Ciprofloxacin and Enalapril 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Omega025ValueForCiprofloxacinAndEnalapril2
:Omega025ValueForCiprofloxacinAndEnalapril2 rdf:type owl:NamedIndividual ,
                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ,
                                                                                                           :enalapril ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 0.55 ;
                                            rdfs:label "Omega025 value for Ciprofloxacin and Enalapril 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Omega025ValueForCiprofloxacinAndLisinopril1
:Omega025ValueForCiprofloxacinAndLisinopril1 rdf:type owl:NamedIndividual ,
                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ,
                                                                                                            :lisinopril ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 0.27 ;
                                             rdfs:label "Omega025 value for Ciprofloxacin and Lisinopril 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Omega025ValueForCiprofloxacinAndLisinopril2
:Omega025ValueForCiprofloxacinAndLisinopril2 rdf:type owl:NamedIndividual ,
                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ,
                                                                                                            :lisinopril ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 0.85 ;
                                             rdfs:label "Omega025 value for Ciprofloxacin and Lisinopril 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Omega025ValueForCiprofloxacinAndRamipril1
:Omega025ValueForCiprofloxacinAndRamipril1 rdf:type owl:NamedIndividual ,
                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ,
                                                                                                          :ramipril ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 0.99 ;
                                           rdfs:label "Omega025 value for Ciprofloxacin and Ramipril 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Omega025ValueForCiprofloxacinAndRamipril2
:Omega025ValueForCiprofloxacinAndRamipril2 rdf:type owl:NamedIndividual ,
                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ,
                                                                                                          :ramipril ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 0.66 ;
                                           rdfs:label "Omega025 value for Ciprofloxacin and Ramipril 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Omega025ValueForEnalaprilAndAmoxicillin1
:Omega025ValueForEnalaprilAndAmoxicillin1 rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :amoxicillin ,
                                                                                                         :enalapril ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> -2.2 ;
                                          rdfs:label "Omega025 value for Enalapril and Amoxicillin 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Omega025ValueForEnalaprilAndAmoxicillin2
:Omega025ValueForEnalaprilAndAmoxicillin2 rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :amoxicillin ,
                                                                                                         :enalapril ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> -0.23 ;
                                          rdfs:label "Omega025 value for Enalapril and Amoxicillin 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Omega025ValueForEnalaprilAndLevofloxacin1
:Omega025ValueForEnalaprilAndLevofloxacin1 rdf:type owl:NamedIndividual ,
                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ,
                                                                                                          :levofloxacin ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> -0.56 ;
                                           rdfs:label "Omega025 value for Enalapril and Levofloxacin 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Omega025ValueForEnalaprilAndLevofloxacin2
:Omega025ValueForEnalaprilAndLevofloxacin2 rdf:type owl:NamedIndividual ,
                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ,
                                                                                                          :levofloxacin ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 0.08 ;
                                           rdfs:label "Omega025 value for Enalapril and Levofloxacin 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#OmegaValueForCiprofloxacinAndEnalapril1
:OmegaValueForCiprofloxacinAndEnalapril1 rdf:type owl:NamedIndividual ,
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ,
                                                                                                        :enalapril ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_expected_count> "2.0"^^xsd:float ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 2.38 ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_number_of_reports> 15 ;
                                         rdfs:label "Omega value for Ciprofloxacin and Enalapril 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#OmegaValueForCiprofloxacinAndEnalapril2
:OmegaValueForCiprofloxacinAndEnalapril2 rdf:type owl:NamedIndividual ,
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ,
                                                                                                        :enalapril ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_expected_count> "30.7"^^xsd:float ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 0.93 ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_number_of_reports> 61 ;
                                         rdfs:label "Omega value for Ciprofloxacin and Enalapril 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#OmegaValueForCiprofloxacinAndLisinopril1
:OmegaValueForCiprofloxacinAndLisinopril1 rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ,
                                                                                                         :lisinopril ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_expected_count> "3.8"^^xsd:float ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 1.3 ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_number_of_reports> 10 ;
                                          rdfs:label "Omega value for Ciprofloxacin and Lisinopril 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#OmegaValueForCiprofloxacinAndLisinopril2
:OmegaValueForCiprofloxacinAndLisinopril2 rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ,
                                                                                                         :lisinopril ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_expected_count> "59.4"^^xsd:float ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 1.11 ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_number_of_reports> 129 ;
                                          rdfs:label "Omega value for Ciprofloxacin and Lisinopril 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#OmegaValueForCiprofloxacinAndRamipril1
:OmegaValueForCiprofloxacinAndRamipril1 rdf:type owl:NamedIndividual ,
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ,
                                                                                                       :ramipril ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_expected_count> "3.2"^^xsd:float ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 1.88 ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_number_of_reports> 13 ;
                                        rdfs:label "Omega value for Ciprofloxacin and Ramipril 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#OmegaValueForCiprofloxacinAndRamipril2
:OmegaValueForCiprofloxacinAndRamipril2 rdf:type owl:NamedIndividual ,
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ,
                                                                                                       :ramipril ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_expected_count> "41.0"^^xsd:float ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 0.99 ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_number_of_reports> 82 ;
                                        rdfs:label "Omega value for Ciprofloxacin and Ramipril 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#OmegaValueForEnalaprilAndAmoxicillin1
:OmegaValueForEnalaprilAndAmoxicillin1 rdf:type owl:NamedIndividual ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :amoxicillin ,
                                                                                                      :enalapril ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_expected_count> "1.4"^^xsd:float ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 0.42 ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_number_of_reports> 2 ;
                                       rdfs:label "Omega value for Enalapril and Amoxicillin 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#OmegaValueForEnalaprilAndAmoxicillin2
:OmegaValueForEnalaprilAndAmoxicillin2 rdf:type owl:NamedIndividual ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :amoxicillin ,
                                                                                                      :enalapril ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_expected_count> "15.2"^^xsd:float ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 0.45 ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_number_of_reports> 21 ;
                                       rdfs:label "Omega value for Enalapril and Amoxicillin 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#OmegaValueForEnalaprilAndFlucloxacillin
:OmegaValueForEnalaprilAndFlucloxacillin rdf:type owl:NamedIndividual ,
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ,
                                                                                                        :flucloxacillin ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_expected_count> "6.6"^^xsd:float ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> -1.01 ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_number_of_reports> 3 ;
                                         rdfs:label "Omega value for Enalapril and Flucloxacillin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#OmegaValueForEnalaprilAndLevofloxacin1
:OmegaValueForEnalaprilAndLevofloxacin1 rdf:type owl:NamedIndividual ,
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ,
                                                                                                       :levofloxacin ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_expected_count> "0.7"^^xsd:float ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 1.49 ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_number_of_reports> 3 ;
                                        rdfs:label "Omega value for Enalapril and Levofloxacin 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#OmegaValueForEnalaprilAndLevofloxacin2
:OmegaValueForEnalaprilAndLevofloxacin2 rdf:type owl:NamedIndividual ,
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ,
                                                                                                       :levofloxacin ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_expected_count> "19.9"^^xsd:float ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 0.63 ;
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_number_of_reports> 31 ;
                                        rdfs:label "Omega value for Enalapril and Levofloxacin 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Onset_10_for_Enalapril
:Onset_10_for_Enalapril rdf:type owl:NamedIndividual ,
                                 <http://www.w3.org/2006/time#DurationDescription> ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                        <http://www.w3.org/2006/time#nominalPosition> "months" ;
                        <http://www.w3.org/2006/time#numericDuration> 12 ;
                        <http://www.w3.org/2006/time#numericPosition> 5 ;
                        rdfs:label "Onset 10 for Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Onset_16_for_Enalapril
:Onset_16_for_Enalapril rdf:type owl:NamedIndividual ,
                                 <http://www.w3.org/2006/time#DurationDescription> ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                        <http://www.w3.org/2006/time#nominalPosition> "years" ;
                        <http://www.w3.org/2006/time#numericPosition> 2 ;
                        rdfs:label "Onset 16 for Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Onset_4_for_Enalapril
:Onset_4_for_Enalapril rdf:type owl:NamedIndividual ,
                                <http://www.w3.org/2006/time#DurationDescription> ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                       <http://www.w3.org/2006/time#nominalPosition> "months" ;
                       <http://www.w3.org/2006/time#numericPosition> 6 ;
                       rdfs:label "Onset 4 for Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Onset_6_for_hydrochlorothiazide
:Onset_6_for_hydrochlorothiazide rdf:type owl:NamedIndividual ,
                                          <http://www.w3.org/2006/time#DurationDescription> ;
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :hydrochlorothiazide ;
                                 <http://www.w3.org/2006/time#nominalPosition> "months" ;
                                 <http://www.w3.org/2006/time#numericDuration> 1 ;
                                 <http://www.w3.org/2006/time#numericPosition> 2 ;
                                 rdfs:label "Onset 6 for hydrochlorothiazide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Onset_7_for_Enalapril
:Onset_7_for_Enalapril rdf:type owl:NamedIndividual ,
                                <http://www.w3.org/2006/time#DurationDescription> ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                       <http://www.w3.org/2006/time#nominalPosition> "months" ;
                       <http://www.w3.org/2006/time#numericDuration> 12 ;
                       <http://www.w3.org/2006/time#numericPosition> 9 ;
                       rdfs:label "Onset 7 for Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Onset_7_for_bisoprolol
:Onset_7_for_bisoprolol rdf:type owl:NamedIndividual ,
                                 <http://www.w3.org/2006/time#DurationDescription> ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :bisoprolol ;
                        <http://www.w3.org/2006/time#nominalPosition> "months" ;
                        <http://www.w3.org/2006/time#numericDuration> 12 ;
                        <http://www.w3.org/2006/time#numericPosition> 9 ;
                        rdfs:label "Onset 7 for bisoprolol" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#OverallReportsInVigibase
:OverallReportsInVigibase rdf:type owl:NamedIndividual ,
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug_drug_interaction> :ciprofloxacin_and_elalapril_interaction ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ciprofloxacin ,
                                                                                                         :enalapril ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 16 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count_of_men> 8 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count_of_women> 8 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_expected_count> "2.0"^^xsd:float ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_max_age> 97 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_median_age> "77.5"^^xsd:float ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_min_age> 42 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                          rdfs:label "Overall reports in Vigibase" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Patient1
:Patient1 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 52 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
          rdfs:label "Patient 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Patient10
:Patient10 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 63 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
           rdfs:label "Patient 10" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Patient11
:Patient11 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 73 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
           rdfs:label "Patient 11" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Patient12
:Patient12 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 81 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
           rdfs:label "Patient 12" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Patient13
:Patient13 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 83 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
           rdfs:label "Patient 13" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Patient14
:Patient14 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 54 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
           rdfs:label "Patient 14" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Patient15
:Patient15 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 42 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
           rdfs:label "Patient 15" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Patient16
:Patient16 rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 97 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
           rdfs:label "Patient 16" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Patient2
:Patient2 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 87 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
          rdfs:label "Patient 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Patient3
:Patient3 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 74 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
          rdfs:label "Patient 3" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Patient4
:Patient4 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 94 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
          rdfs:label "Patient 4" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Patient5
:Patient5 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 61 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
          rdfs:label "Patient 5" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Patient6
:Patient6 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 85 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "female" ;
          rdfs:label "Patient 6" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Patient7
:Patient7 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 89 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
          rdfs:label "Patient 7" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Patient8
:Patient8 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 62 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
          rdfs:label "Patient 8" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Patient9
:Patient9 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Patient> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_age> 86 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_gender> "male" ;
          rdfs:label "Patient 9" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#RateRatioOfAcuteKidneyFailureWithCiprofloxacin
:RateRatioOfAcuteKidneyFailureWithCiprofloxacin rdf:type owl:NamedIndividual ,
                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_supported_by_statistical_entity> :CIForCiprofloxacinAndAKI ;
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 2.76 ;
                                                rdfs:label "Rate Ratio of acute kidney failure with ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#RateRatioOfAcuteKidneyFailureWithCurrentFluoroquinoloneUse
:RateRatioOfAcuteKidneyFailureWithCurrentFluoroquinoloneUse rdf:type owl:NamedIndividual ,
                                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_supported_by_statistical_entity> :CIForFluorquinolonesAndAKI ;
                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :fluroquinolones ;
                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 2.18 ;
                                                            rdfs:label "Rate Ratio of acute kidney failure with current fluoroquinolone use" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#RateRatioOfAcuteKidneyFailureWithrenin-angiotensinSystemBlockers
:RateRatioOfAcuteKidneyFailureWithrenin-angiotensinSystemBlockers rdf:type owl:NamedIndividual ,
                                                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_supported_by_statistical_entity> :CIForrenin-angiotensinSystemBlockersAndAKI ;
                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ACE_inhibitors ;
                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 1.0 ;
                                                                  rdfs:label "Rate Ratio of acute kidney failure with renin-angiotensin system blockers" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#RateRatioOfAcuteKidneyFailureWithrenin-angiotensinSystemBlockersANDCiprofloxacin
:RateRatioOfAcuteKidneyFailureWithrenin-angiotensinSystemBlockersANDCiprofloxacin rdf:type owl:NamedIndividual ,
                                                                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Statistical_Entity> ;
                                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_supported_by_statistical_entity> :CIForrenin-angiotensinSystemBlockersCombinedWithCiprofloxacinAndAKI ;
                                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ACE_inhibitors ,
                                                                                                                                                 :ciprofloxacin ;
                                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 4.46 ;
                                                                                  rdfs:label "Rate Ratio of acute kidney failure with renin-angiotensin system blockers AND ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Ref.1
:Ref.1 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Bird ST, Etminan M, Brophy JM, Hartzema AG,
Delaney JAC. Risk of acute kidney injury
associated with the use of fluoroquinolones.
CMAJ 2013;185: E475-E482.""" ;
       rdfs:label "Ref.1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Ref.2
:Ref.2 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Lomaestro BM. Fluoroquinolone-induced
renal failure. Drug Saf. 2000;22:479-85.""" ;
       rdfs:label "Ref.2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Ref.3
:Ref.3 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Electronic Medicines Compendium:
Summary of Product Characteristics for
enalapril (Innovace®). Available from:
https://www.medicines.org.uk/emc/
medicine/1180. Accessed: 19 September 2016.""" ;
       rdfs:label "Ref.3" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Ref.4
:Ref.4 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Drug consult: ACE inhibitor induced renal
failure. Micromedex® Healthcare Series.
[Online] Greenwood Village (Co): Thomson
Micromedex. Available from:
http://www.micromedexsolutions.com.""" ;
       rdfs:label "Ref.4" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Ref.5
:Ref.5 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Norén GN, Sundberg R, Bate A, Edwards IR.
A statistical methodology for drug-drug
interaction surveillance. Stat Med. 2008 Jul
20;27(16):3057-70.""" ;
       rdfs:label "Ref.5" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Ref.6
:Ref.6 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """US Food and Drug Administration: Product
label for enalapril (Vasotec®). Available
from: http:// www.accessdata.fda.gov/
drugsatfda_docs/label/2015/018998s080lbl.
pdf. Accessed: 26 January 2017.""" ;
       rdfs:label "Ref.6" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Ref.7
:Ref.7 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """Electronic Medicines Compendium.
Summary of Product Characteristics for
ciprofloxacin. Available from:
https://www.medicines.org.uk/emc/
medicine/32450. Accessed: 19 September 2016.""" ;
       rdfs:label "Ref.7" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Ref.8
:Ref.8 rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Bibliographic_reference> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> """US Food and Drug Administration: Product
label for ciprofloxacin (Cipro®). Available
from: http://www. accessdata.fda.gov/
drugsatfda_docs/label/2016/019537s085,
020780s042lbl.pdf. Accessed: 26 January 2017.""" ;
       rdfs:label "Ref.8" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report1
:Report1 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :clonazepam ,
                                                                                    :colecalciferol ,
                                                                                    :lorazepam ,
                                                                                    :mirtazapine ,
                                                                                    :tiotropium ,
                                                                                    <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#fluticasone/salmeterol> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interacting_drug> :ciprofloxacin ,
                                                                                    :enalapril ,
                                                                                    :metformin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_past_diagnosis> :hypertension ,
                                                                                  :type2DiabetesMellitus ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient1 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :Usage_for_report_1_for_ciprofloxacin ,
                                                                                       :Usage_for_report_1_for_enalapril ,
                                                                                       :Usage_for_report_1_for_metformin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Report1OnsetForCiprofloxacin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovering" ;
         rdfs:label "Report 1" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report10
:Report10 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :CommentsOnReport10 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :omeprazole ,
                                                                                     :pentoxifylline ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interacting_drug> :ciprofloxacin ,
                                                                                     :enalapril ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_past_diagnosis> :hypertension ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient10 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :Usage_for_report_10_for_ciprofloxacin ,
                                                                                        :Usage_for_report_10_for_enalapril ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Report10OnsetForCiprofloxacin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovering" ;
          rdfs:label "Report 10" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report10DosageForCiprofloxacin
:Report10DosageForCiprofloxacin rdf:type owl:NamedIndividual ,
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "1000 mg" ;
                                rdfs:label "Report 10 dosage for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report10DosageForEnalapril
:Report10DosageForEnalapril rdf:type owl:NamedIndividual ,
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "20 mg" ;
                            rdfs:label "Report 10 dosage for Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report10OnsetForCiprofloxacin
:Report10OnsetForCiprofloxacin rdf:type owl:NamedIndividual ,
                                        <http://www.w3.org/2006/time#DurationDescription> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                               <http://www.w3.org/2006/time#nominalPosition> "days" ;
                               <http://www.w3.org/2006/time#numericPosition> 6 ;
                               rdfs:label "Onset 10 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report10RouteOfAdministrationOfEnalapril
:Report10RouteOfAdministrationOfEnalapril rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                          rdfs:label "Report 10 route of administration of Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report10RouteOfAdministrationOfciprofloxacin
:Report10RouteOfAdministrationOfciprofloxacin rdf:type owl:NamedIndividual ,
                                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                              rdfs:label "Report 10 route of administration of ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report11
:Report11 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :digoxin ,
                                                                                     :triazolam ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient11 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ciprofloxacin ,
                                                                                         :enalapril ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :Usage_for_report_11_for_ciprofloxacin ,
                                                                                        :Usage_for_report_11_for_enalapril ,
                                                                                        :Usage_for_report_11_for_furosemide ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :furosemide ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Report11OnsetForCiprofloxacin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after drug withdrawal" ;
          rdfs:label "Report 11" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report11DosageForCiprofloxacin
:Report11DosageForCiprofloxacin rdf:type owl:NamedIndividual ,
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "1000 mg" ;
                                rdfs:label "Report 11 dosage for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report11DosageForEnalapril
:Report11DosageForEnalapril rdf:type owl:NamedIndividual ,
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "2.5 mg" ;
                            rdfs:label "Report 11 dosage for Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report11DosageForFurosemide
:Report11DosageForFurosemide rdf:type owl:NamedIndividual ,
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :furosemide ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "125 mg" ;
                             rdfs:label "Report 11 dosage for furosemide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report11OnsetForCiprofloxacin
:Report11OnsetForCiprofloxacin rdf:type owl:NamedIndividual ,
                                        <http://www.w3.org/2006/time#DurationDescription> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                               <http://www.w3.org/2006/time#nominalPosition> "days" ;
                               <http://www.w3.org/2006/time#numericPosition> 11 ;
                               rdfs:label "Onset 11 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report11OnsetForEnalapril
:Report11OnsetForEnalapril rdf:type owl:NamedIndividual ,
                                    <http://www.w3.org/2006/time#DurationDescription> ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                           <http://www.w3.org/2006/time#nominalPosition> "days" ;
                           <http://www.w3.org/2006/time#numericPosition> 5 ;
                           rdfs:label "Onset 11 for Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report11RouteOfAdministrationOfCiprofloxacin
:Report11RouteOfAdministrationOfCiprofloxacin rdf:type owl:NamedIndividual ,
                                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                              rdfs:label "Report 11 route of administration of ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report11RouteOfAdministrationOfEnalapril
:Report11RouteOfAdministrationOfEnalapril rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                          rdfs:label "Report 11 route of administration of Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report11RouteOfAdministrationOfFurosemide
:Report11RouteOfAdministrationOfFurosemide rdf:type owl:NamedIndividual ,
                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :furosemide ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                           rdfs:label "Report 11 route of administration of furosemide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report12
:Report12 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :CommentsOnReport12 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :insulin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_past_diagnosis> :bladder_cancer ,
                                                                                   :chronicRenalFailure ,
                                                                                   :macrohaematuria ,
                                                                                   :type2DiabetesMellitus ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient12 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ciprofloxacin ,
                                                                                         :enalapril ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :Usage_for_report_12_for_acenocoumarol ,
                                                                                        :Usage_for_report_12_for_ciprofloxacin ,
                                                                                        :Usage_for_report_12_for_dronedarone ,
                                                                                        :Usage_for_report_12_for_enalapril ,
                                                                                        :Usage_for_report_12_for_sitagliptin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :acenocoumarol ,
                                                                                           :dronedarone ,
                                                                                           :sitagliptin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Report12OnsetForCiprofloxacin ;
          rdfs:label "Report 12" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report12DosageForCiprofloxacin
:Report12DosageForCiprofloxacin rdf:type owl:NamedIndividual ,
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "500 mg" ;
                                rdfs:label "Report 12 dosage for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report12DosageForDronedarone
:Report12DosageForDronedarone rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :dronedarone ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "400 mg" ;
                              rdfs:label "Report 12 dosage for dronedarone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report12DosageForEnalapril
:Report12DosageForEnalapril rdf:type owl:NamedIndividual ,
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "5 mg" ;
                            rdfs:label "Report 12 dosage for Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report12OnsetForCiprofloxacin
:Report12OnsetForCiprofloxacin rdf:type owl:NamedIndividual ,
                                        <http://www.w3.org/2006/time#DurationDescription> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                               <http://www.w3.org/2006/time#nominalPosition> "days" ;
                               <http://www.w3.org/2006/time#numericPosition> 43 ;
                               rdfs:label "Onset 12 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report12RouteOfAdministrationOfAcenocoumarol
:Report12RouteOfAdministrationOfAcenocoumarol rdf:type owl:NamedIndividual ,
                                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :acenocoumarol ;
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                              rdfs:label "Report 12 route of administration of acenocoumarol" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report12RouteOfAdministrationOfCiprofloxacin
:Report12RouteOfAdministrationOfCiprofloxacin rdf:type owl:NamedIndividual ,
                                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                              rdfs:label "Report 12 route of administration of ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report12RouteOfAdministrationOfDronedarone
:Report12RouteOfAdministrationOfDronedarone rdf:type owl:NamedIndividual ,
                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :dronedarone ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                            rdfs:label "Report 12 route of administration of       dronedarone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report12RouteOfAdministrationOfEnalapril
:Report12RouteOfAdministrationOfEnalapril rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                          rdfs:label "Report 12 route of administration of Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report12RouteOfAdministrationOfSitagliptin
:Report12RouteOfAdministrationOfSitagliptin rdf:type owl:NamedIndividual ,
                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :sitagliptin ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                            rdfs:label "Report 12 route of administration of sitagliptin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report13
:Report13 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ,
                                                                                   :paraneoplastic_syndrome ,
                                                                                   <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#lyell'sSyndrome> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_past_diagnosis> :adenocarcinoma ,
                                                                                   :chronicRenalFailure ,
                                                                                   :hypertension ,
                                                                                   :hyperuricaemia ,
                                                                                   :renal_anaemia ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient13 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ciprofloxacin ,
                                                                                         :enalapril ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :Usage_for_report_13_for_allopurinol ,
                                                                                        :Usage_for_report_13_for_ciprofloxacin ,
                                                                                        :Usage_for_report_13_for_enalapril ,
                                                                                        :Usage_for_report_13_for_moxifloxacin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :allopurinol ,
                                                                                           :moxifloxacin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Report13OnsetForCiprofloxacin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "unknown" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "unknown" ;
          rdfs:label "Report 13" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report13DosageForAllopurinol
:Report13DosageForAllopurinol rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :allopurinol ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "300 mg" ;
                              rdfs:label "Report 13 dosage for allopurinol" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report13DosageForEnalapril
:Report13DosageForEnalapril rdf:type owl:NamedIndividual ,
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "20 mg" ;
                            rdfs:label "Report 13 dosage for Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report13OnsetForCiprofloxacin
:Report13OnsetForCiprofloxacin rdf:type owl:NamedIndividual ,
                                        <http://www.w3.org/2006/time#DurationDescription> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                               <http://www.w3.org/2006/time#nominalPosition> "days" ;
                               <http://www.w3.org/2006/time#numericPosition> 3 ;
                               rdfs:label "Onset 13 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report13OnsetForMoxifloxacin
:Report13OnsetForMoxifloxacin rdf:type owl:NamedIndividual ,
                                       <http://www.w3.org/2006/time#DurationDescription> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :moxifloxacin ;
                              <http://www.w3.org/2006/time#nominalPosition> "days" ;
                              <http://www.w3.org/2006/time#numericPosition> 0 ;
                              rdfs:label "Onset 13 for moxifloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report13RouteOfAdministrationOfAllopurinol
:Report13RouteOfAdministrationOfAllopurinol rdf:type owl:NamedIndividual ,
                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :allopurinol ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                            rdfs:label "Report 13 route of administration of allopurinol" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report13RouteOfAdministrationOfCiprofloxacin
:Report13RouteOfAdministrationOfCiprofloxacin rdf:type owl:NamedIndividual ,
                                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                              rdfs:label "Report 13 route of administration of ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report13RouteOfAdministrationOfEnalapril
:Report13RouteOfAdministrationOfEnalapril rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                          rdfs:label "Report 13 route of administration of Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report14
:Report14 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :CommentsOnReport14 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ,
                                                                                   :cellulitis ,
                                                                                   :diarrhoea ,
                                                                                   :hypertensiveHeartDisease ,
                                                                                   :klebsiellaInfection ,
                                                                                   :osteomyelitis ,
                                                                                   :pancytopenia ,
                                                                                   :pneumonia ,
                                                                                   :sepsis ,
                                                                                   :tubulo-interstitialNephritis ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_past_diagnosis> :dyslipidaemia ,
                                                                                   :gout ,
                                                                                   :hypertension ,
                                                                                   :type2DiabetesMellitus ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient14 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ciprofloxacin ,
                                                                                         :enalapril ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :Usage_for_report_14_for_ceftriaxone ,
                                                                                        :Usage_for_report_14_for_telavancin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :allopurinol ,
                                                                                           :cefepime ,
                                                                                           :ceftriaxone ,
                                                                                           :metformin ,
                                                                                           :telavancin ,
                                                                                           <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#amoxicillin/clavulanate> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Report14OnsetForTelavancin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after drug withdrawal" ;
          rdfs:label "Report 14" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report14OnsetForCeftriaxone
:Report14OnsetForCeftriaxone rdf:type owl:NamedIndividual ,
                                      <http://www.w3.org/2006/time#DurationDescription> ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ceftriaxone ;
                             <http://www.w3.org/2006/time#nominalPosition> "days" ;
                             <http://www.w3.org/2006/time#numericPosition> 30 ;
                             rdfs:label "Onset 14 for ceftriaxone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report14OnsetForTelavancin
:Report14OnsetForTelavancin rdf:type owl:NamedIndividual ,
                                     <http://www.w3.org/2006/time#DurationDescription> ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :telavancin ;
                            <http://www.w3.org/2006/time#nominalPosition> "days" ;
                            <http://www.w3.org/2006/time#numericPosition> 17 ;
                            rdfs:label "Onset 14 for telavancin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report14RouteOfAdministrationOfCeftriaxone
:Report14RouteOfAdministrationOfCeftriaxone rdf:type owl:NamedIndividual ,
                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ceftriaxone ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "injected" ;
                                            rdfs:label "Report 14 route of administration of ceftriaxone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report14RouteOfAdministrationOfTelavancin
:Report14RouteOfAdministrationOfTelavancin rdf:type owl:NamedIndividual ,
                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :telavancin ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "injected (intraveneous)" ;
                                           rdfs:label "Report 14 route of administration of telavancin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report15
:Report15 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :CommentsOnReport15 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ,
                                                                                   :deviceRelatedInfection ,
                                                                                   :pneumonia ,
                                                                                   :rash ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_past_diagnosis> :copd ,
                                                                                   :hypertension ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient15 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ciprofloxacin ,
                                                                                         :enalapril ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :Usage_for_report_15_for_carboplatin ,
                                                                                        :Usage_for_report_15_for_ciprofloxacin ,
                                                                                        :Usage_for_report_15_for_enalapril ,
                                                                                        :Usage_for_report_15_for_oxacillin ,
                                                                                        :Usage_for_report_15_for_paclitaxel ,
                                                                                        :Usage_for_report_15_for_vancomycin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :carboplatin ,
                                                                                           :oxacillin ,
                                                                                           :paclitaxel ,
                                                                                           :vancomycin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Report15OnsetForCarboplatin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after drug withdrawal" ;
          rdfs:label "Report 15" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report15DosageForCarboplatin
:Report15DosageForCarboplatin rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :carboplatin ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "703 mg" ;
                              rdfs:label "Report 15 dosage for carboplatin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report15DosageForPaclitaxel
:Report15DosageForPaclitaxel rdf:type owl:NamedIndividual ,
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :paclitaxel ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "340 mg" ;
                             rdfs:label "Report 15 dosage for paclitaxel" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report15OnsetForCarboplatin
:Report15OnsetForCarboplatin rdf:type owl:NamedIndividual ,
                                      <http://www.w3.org/2006/time#DurationDescription> ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :carboplatin ;
                             <http://www.w3.org/2006/time#nominalPosition> "days" ;
                             <http://www.w3.org/2006/time#numericPosition> 12 ;
                             rdfs:label "Onset 15 for carboplatin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report15OnsetForPaclitaxel
:Report15OnsetForPaclitaxel rdf:type owl:NamedIndividual ,
                                     <http://www.w3.org/2006/time#DurationDescription> ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :paclitaxel ;
                            <http://www.w3.org/2006/time#nominalPosition> "days" ;
                            <http://www.w3.org/2006/time#numericPosition> 12 ;
                            rdfs:label "Onset 15 for paclitaxel" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report15RouteOfAdministrationOfCarboplatin
:Report15RouteOfAdministrationOfCarboplatin rdf:type owl:NamedIndividual ,
                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :carboplatin ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "injected (intraveneous)" ;
                                            rdfs:label "Report 15 route of administration of carboplatin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report15RouteOfAdministrationOfPaclitaxel
:Report15RouteOfAdministrationOfPaclitaxel rdf:type owl:NamedIndividual ,
                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :paclitaxel ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "injected (intraveneous)" ;
                                           rdfs:label "Report 15 route of administration of paclitaxel" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report16
:Report16 rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ,
                                                                                   <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#serum_creatinine_501_mmol/L> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interacting_drug> :ciprofloxacin ,
                                                                                     :enalapril ,
                                                                                     :furosemide ,
                                                                                     :metamizole ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_past_diagnosis> :chronicRenalFailure ,
                                                                                   :hypertension ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient16 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :Usage_for_report_16_for_ciprofloxacin ,
                                                                                        :Usage_for_report_16_for_enalapril ,
                                                                                        :Usage_for_report_16_for_furosemide ,
                                                                                        :Usage_for_report_16_for_metamizole ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Report16OnsetForCiprofloxacin ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after drug withdrawal" ;
          rdfs:label "Report 16" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report16OnsetForCiprofloxacin
:Report16OnsetForCiprofloxacin rdf:type owl:NamedIndividual ,
                                        <http://www.w3.org/2006/time#DurationDescription> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                               <http://www.w3.org/2006/time#nominalPosition> "days" ;
                               <http://www.w3.org/2006/time#numericPosition> 0 ;
                               rdfs:label "Onset 16 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report16OnsetForMetamizole
:Report16OnsetForMetamizole rdf:type owl:NamedIndividual ,
                                     <http://www.w3.org/2006/time#DurationDescription> ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :metamizole ;
                            <http://www.w3.org/2006/time#nominalPosition> "days" ;
                            <http://www.w3.org/2006/time#numericPosition> 2 ;
                            rdfs:label "Onset 16 for metamizole" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report1DosageForCiprofloxacin
:Report1DosageForCiprofloxacin rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "1000 mg" ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_process> "true"^^xsd:boolean ;
                               rdfs:label "Dosage for Report 1 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report1DosageForEnalapril
:Report1DosageForEnalapril rdf:type owl:NamedIndividual ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "50 mg" ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_process> "true"^^xsd:boolean ;
                           rdfs:label "Dosage for Report 1 for Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report1DosageForMetformin
:Report1DosageForMetformin rdf:type owl:NamedIndividual ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :metformin ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "1700 mg" ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_process> "true"^^xsd:boolean ;
                           rdfs:label "Dosage for Report 1 for metformin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report1OnsetForCiprofloxacin
:Report1OnsetForCiprofloxacin rdf:type owl:NamedIndividual ,
                                       <http://www.w3.org/2006/time#DurationDescription> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                              <http://www.w3.org/2006/time#nominalPosition> "days" ;
                              <http://www.w3.org/2006/time#numericPosition> 6 ;
                              rdfs:label "Onset 1 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report1RouteOfAdministrationOfEnalapril
:Report1RouteOfAdministrationOfEnalapril rdf:type owl:NamedIndividual ,
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                         rdfs:label "Report 1 route of administration of Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report1RouteOfAdministrationOfMetformin
:Report1RouteOfAdministrationOfMetformin rdf:type owl:NamedIndividual ,
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :metformin ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                         rdfs:label "Report 1 route of administration of  metformin " .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report1RouteOfAdministrationOfciprofloxacin
:Report1RouteOfAdministrationOfciprofloxacin rdf:type owl:NamedIndividual ,
                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                             rdfs:label "Report 1 route of administration of ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report2
:Report2 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :CommentsOnReport2 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report2RouteOfAdministrationOfCiprofloxacin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ,
                                                                                  :bloodGlucoseUncontrolled ,
                                                                                  :diarrhoea ,
                                                                                  :speechAndWalkingProblems ,
                                                                                  :walking_problems ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :risperidone ,
                                                                                    :rivaroxaban ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interacting_drug> :ciprofloxacin ,
                                                                                    :enalapril ,
                                                                                    :ibuprofen ,
                                                                                    :pravastatin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_past_diagnosis> :chronicRenalFailure ,
                                                                                  :diarrhoea ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient2 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :Usage_for_report_2_for_ciprofloxacin ,
                                                                                       :Usage_for_report_2_for_enalapril ,
                                                                                       :Usage_for_report_2_for_ibuprofen ,
                                                                                       :Usage_for_report_2_for_pravastatin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Report2OnsetForCiprofloxacin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after drug withdrawal" ;
         rdfs:label "Report 2" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report2OnsetForCiprofloxacin
:Report2OnsetForCiprofloxacin rdf:type owl:NamedIndividual ,
                                       <http://www.w3.org/2006/time#DurationDescription> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                              <http://www.w3.org/2006/time#nominalPosition> "days" ;
                              <http://www.w3.org/2006/time#numericPosition> 5 ;
                              rdfs:label "Onset 2 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report2RouteOfAdministrationOfCiprofloxacin
:Report2RouteOfAdministrationOfCiprofloxacin rdf:type owl:NamedIndividual ,
                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                             rdfs:label "Report 2 route of administration of ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report2RouteOfAdministrationOfEnalapril
:Report2RouteOfAdministrationOfEnalapril rdf:type owl:NamedIndividual ,
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                         rdfs:label "Report 2 route of administration of Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report2RouteOfAdministrationOfIbuprofen
:Report2RouteOfAdministrationOfIbuprofen rdf:type owl:NamedIndividual ,
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ibuprofen ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                         rdfs:label "Report 2 route of administration of ibuprofen" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report2RouteOfAdministrationOfpravastatin
:Report2RouteOfAdministrationOfpravastatin rdf:type owl:NamedIndividual ,
                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :pravastatin ;
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                           rdfs:label "Report 2 route of administration of pravastatin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report3
:Report3 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :CommentsOnReport3 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :acenocoumarol ,
                                                                                    :bisoprolol ,
                                                                                    :deflazacort ,
                                                                                    :glimepiride ,
                                                                                    :metformin ,
                                                                                    :oxazepam ,
                                                                                    :pantoprazole ,
                                                                                    :simvastatin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_past_diagnosis> :cardiomyopathy ,
                                                                                  :peripheral_obliterating_arteriopathy ,
                                                                                  :septic_arthritis ,
                                                                                  :type2DiabetesMellitus ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient3 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ciprofloxacin ,
                                                                                        :enalapril ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :Usage_for_report_3_for_ciprofloxacin ,
                                                                                       :Usage_for_report_3_for_enalapril ,
                                                                                       :Usage_for_report_3_for_methotrexate ,
                                                                                       :Usage_for_report_3_for_metolazone ,
                                                                                       :Usage_for_report_3_for_torasemide ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :methotrexate ,
                                                                                          :metolazone ,
                                                                                          :torasemide ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Report3OnsetForCiprofloxacin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "negative - condition still applied" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "no recovery" ;
         rdfs:label "Report 3" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report3DosageForEnalapril
:Report3DosageForEnalapril rdf:type owl:NamedIndividual ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "20 mg" ;
                           rdfs:label "Report 3 dosage for Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report3DosageForMethotrexate
:Report3DosageForMethotrexate rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :methotrexate ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_week_interval ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "One dose weekly " ;
                              rdfs:label "Report 3 dosage for methotrexate" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report3DosageForMetolazone
:Report3DosageForMetolazone rdf:type owl:NamedIndividual ,
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :metolazone ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_week_interval ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "5 mg" ;
                            rdfs:label "Report 3 dosage for metolazone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report3DosageForTorasemide
:Report3DosageForTorasemide rdf:type owl:NamedIndividual ,
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :torasemide ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "5 mg" ;
                            rdfs:label "Report 3 dosage for torasemide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report3OnsetForCiprofloxacin
:Report3OnsetForCiprofloxacin rdf:type owl:NamedIndividual ,
                                       <http://www.w3.org/2006/time#DurationDescription> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                              <http://www.w3.org/2006/time#nominalPosition> "days" ;
                              <http://www.w3.org/2006/time#numericPosition> 12 ;
                              rdfs:label "Onset 3 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report3RouteOfAdministrationOfCiprofloxacin
:Report3RouteOfAdministrationOfCiprofloxacin rdf:type owl:NamedIndividual ,
                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                             rdfs:label "Report 3 route of administration of ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report3RouteOfAdministrationOfEnalapril
:Report3RouteOfAdministrationOfEnalapril rdf:type owl:NamedIndividual ,
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                         rdfs:label "Report 3 route of administration of Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report3RouteOfAdministrationOfMetolazone
:Report3RouteOfAdministrationOfMetolazone rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :metolazone ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                          rdfs:label "Report 3 route of administration of metolazone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report3RouteOfAdministrationOfTorasemide
:Report3RouteOfAdministrationOfTorasemide rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :torasemide ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                          rdfs:label "Report 3 route of administration of torasemide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report3RouteOfAdministrationOfmethotrexate
:Report3RouteOfAdministrationOfmethotrexate rdf:type owl:NamedIndividual ,
                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :methotrexate ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "subcutaneous" ;
                                            rdfs:label "Report 3 route of administration of methotrexate" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report4
:Report4 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ,
                                                                                  :diarrhoea ,
                                                                                  :hyponatraemia ,
                                                                                  :vomiting ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :acetylsalicylicAcid ,
                                                                                    :folic ,
                                                                                    :glycerylTrinitrate ,
                                                                                    :omeprazole ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient4 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ciprofloxacin ,
                                                                                        :enalapril ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :Usage_for_report_4_for_ciprofloxacin ,
                                                                                       :Usage_for_report_4_for_enalapril ,
                                                                                       :Usage_for_report_4_for_furosemide ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :furosemide ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Report4OnsetForCiprofloxacin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovering" ;
         rdfs:label "Report 4" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report4DosageForEnalapril
:Report4DosageForEnalapril rdf:type owl:NamedIndividual ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "5 mg" ;
                           rdfs:label "Report 4 dosage for Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report4OnsetForCiprofloxacin
:Report4OnsetForCiprofloxacin rdf:type owl:NamedIndividual ,
                                       <http://www.w3.org/2006/time#DurationDescription> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                              <http://www.w3.org/2006/time#nominalPosition> "days" ;
                              <http://www.w3.org/2006/time#numericPosition> 5 ;
                              rdfs:label "Onset 4 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report4OnsetForFurosemide
:Report4OnsetForFurosemide rdf:type owl:NamedIndividual ,
                                    <http://www.w3.org/2006/time#DurationDescription> ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :furosemide ;
                           <http://www.w3.org/2006/time#nominalPosition> "days" ;
                           <http://www.w3.org/2006/time#numericPosition> 13 ;
                           rdfs:label "Onset 4 for furosemide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report4RouteOfAdministrationOfCiprofloxacin
:Report4RouteOfAdministrationOfCiprofloxacin rdf:type owl:NamedIndividual ,
                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                             rdfs:label "Report 4 route of administration of ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report4RouteOfAdministrationOfEnalapril
:Report4RouteOfAdministrationOfEnalapril rdf:type owl:NamedIndividual ,
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                         rdfs:label "Report 4 route of administration of Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report4RouteOfAdministrationOfFurosemide
:Report4RouteOfAdministrationOfFurosemide rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :furosemide ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                          rdfs:label "Report 4 route of administration of furosemide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report5
:Report5 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ,
                                                                                  :dehydration ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interacting_drug> :ciprofloxacin ,
                                                                                    :enalapril ,
                                                                                    :furosemide ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_past_diagnosis> :hypertension ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient5 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :Usage_for_report_5_for_ciprofloxacin ,
                                                                                       :Usage_for_report_5_for_enalapril ,
                                                                                       :Usage_for_report_5_for_furosemide ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Report5OnsetForCiprofloxacin ,
                                                                       :Report5OnsetForfurosemide ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after drug withdrawal" ;
         rdfs:label "Report 5" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report5OnsetForCiprofloxacin
:Report5OnsetForCiprofloxacin rdf:type owl:NamedIndividual ,
                                       <http://www.w3.org/2006/time#DurationDescription> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                              <http://www.w3.org/2006/time#nominalPosition> "days" ;
                              <http://www.w3.org/2006/time#numericPosition> 7 ;
                              rdfs:label "Onset 5 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report5OnsetForEnalapril
:Report5OnsetForEnalapril rdf:type owl:NamedIndividual ,
                                   <http://www.w3.org/2006/time#DurationDescription> ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                          <http://www.w3.org/2006/time#nominalPosition> "days" ;
                          <http://www.w3.org/2006/time#numericPosition> 7 ;
                          rdfs:label "Onset 5 for Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report5OnsetForfurosemide
:Report5OnsetForfurosemide rdf:type owl:NamedIndividual ,
                                    <http://www.w3.org/2006/time#DurationDescription> ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :furosemide ;
                           <http://www.w3.org/2006/time#nominalPosition> "days" ;
                           <http://www.w3.org/2006/time#numericPosition> 7 ;
                           rdfs:label "Onset 5 for furosemide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report5RouteOfAdministrationOfCiprofloxacin
:Report5RouteOfAdministrationOfCiprofloxacin rdf:type owl:NamedIndividual ,
                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                             rdfs:label "Report 5 route of administration of ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report5RouteOfAdministrationOfEnalapril
:Report5RouteOfAdministrationOfEnalapril rdf:type owl:NamedIndividual ,
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                         rdfs:label "Report 5 route of administration of Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report5RouteOfAdministrationOffurosemide
:Report5RouteOfAdministrationOffurosemide rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :furosemide ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                          rdfs:label "Report 5 route of administration of furosemide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report6
:Report6 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ,
                                                                                  :hypotension ,
                                                                                  :hypoxia ,
                                                                                  :nausea ,
                                                                                  :tachycardia ,
                                                                                  :tachypnoea ,
                                                                                  :vomiting ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :alprazolam ,
                                                                                    :ipratropium ,
                                                                                    :metformin ,
                                                                                    :omeprazole ,
                                                                                    :simvastatin ,
                                                                                    :trimetazidine ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interacting_drug> :ciprofloxacin ,
                                                                                    :enalapril ,
                                                                                    :hydrochlorothiazide ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_past_diagnosis> :acute_bronchitis ,
                                                                                  :dizziness ,
                                                                                  :dyslipidaemia ,
                                                                                  :glaucoma ,
                                                                                  :hypertension ,
                                                                                  :type2DiabetesMellitus ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient6 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :Usage_for_report_6_for_ciprofloxacin ,
                                                                                       :Usage_for_report_6_for_enalapril ,
                                                                                       :Usage_for_report_6_for_hydrochlorothiazide ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Onset_6_for_hydrochlorothiazide ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after drug withdrawal" ;
         rdfs:label "Report 6" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report6DosageForCiprofloxacin
:Report6DosageForCiprofloxacin rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "1.0 g" ;
                               rdfs:label "Report 6 dosage for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report6DosageForEnalapril
:Report6DosageForEnalapril rdf:type owl:NamedIndividual ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "20 mg" ;
                           rdfs:label "Report 6 dosage for Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report6DosageForHydrochlorothiazide
:Report6DosageForHydrochlorothiazide rdf:type owl:NamedIndividual ,
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :hydrochlorothiazide ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "12.5 mg" ;
                                     rdfs:label "Report 6 dosage for hydrochlorothiazide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report6OnsetForCiprofloxacin
:Report6OnsetForCiprofloxacin rdf:type owl:NamedIndividual ,
                                       <http://www.w3.org/2006/time#DurationDescription> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                              <http://www.w3.org/2006/time#nominalPosition> "days" ;
                              <http://www.w3.org/2006/time#numericPosition> 6 ;
                              rdfs:label "Onset 6 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report6RouteOfAdministrationOfCiprofloxacin
:Report6RouteOfAdministrationOfCiprofloxacin rdf:type owl:NamedIndividual ,
                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                             rdfs:label "Report 6 route of administration of ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report6RouteOfAdministrationOfEnalapril
:Report6RouteOfAdministrationOfEnalapril rdf:type owl:NamedIndividual ,
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                         rdfs:label "Report 6 route of administration of Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report6RouteOfAdministrationOfHydrochlorothiazide
:Report6RouteOfAdministrationOfHydrochlorothiazide rdf:type owl:NamedIndividual ,
                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :hydrochlorothiazide ;
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                                   rdfs:label "Report 6 route of administration of hydrochlorothiazide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report7
:Report7 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :alprazolam ,
                                                                                    :paracetamol ,
                                                                                    :ranitidine ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interacting_drug> :bisoprolol ,
                                                                                    :ciprofloxacin ,
                                                                                    :enalapril ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_past_diagnosis> :chronicRenalFailure ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient7 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :Usage_for_report_7_for_bisoprolol ,
                                                                                       :Usage_for_report_7_for_ciprofloxacin ,
                                                                                       :Usage_for_report_7_for_enalapril ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Report7OnsetForCiprofloxacin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovery after drug withdrawal" ;
         rdfs:label "Report 7" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report7OnsetForCiprofloxacin
:Report7OnsetForCiprofloxacin rdf:type owl:NamedIndividual ,
                                       <http://www.w3.org/2006/time#DurationDescription> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                              <http://www.w3.org/2006/time#nominalPosition> "days" ;
                              <http://www.w3.org/2006/time#numericPosition> 4 ;
                              rdfs:label "Onset 7 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report7RouteOfAdministrationOfBisoprolol
:Report7RouteOfAdministrationOfBisoprolol rdf:type owl:NamedIndividual ,
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :bisoprolol ;
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                          rdfs:label "Route of administration of bisoprolol for report 7" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report7RouteOfAdministrationOfCiprofloxacin
:Report7RouteOfAdministrationOfCiprofloxacin rdf:type owl:NamedIndividual ,
                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                             rdfs:label "Route of administration of ciprofloxacin for report 7" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report7RouteOfAdministrationOfEnalapril
:Report7RouteOfAdministrationOfEnalapril rdf:type owl:NamedIndividual ,
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                         rdfs:label "Route of administration of Enalapril for report 7" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report8
:Report8 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :CommentsOnReport8 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ,
                                                                                  <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#serumCreatinine300mmol/L> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_past_diagnosis> :hypertension ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient8 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_primary_suspect_drug> :ciprofloxacin ,
                                                                                        :enalapril ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :Usage_for_report_8_for_ciprofloxacin ,
                                                                                       :Usage_for_report_8_for_enalapril ,
                                                                                       :Usage_for_report_8_for_ibuprofen ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_secondary_suspect_drug> :ibuprofen ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Report8OnsetForCiprofloxacin ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "positive - condition not applied" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "recovering" ;
         rdfs:label "Report 8" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report8OnsetForCiprofloxacin
:Report8OnsetForCiprofloxacin rdf:type owl:NamedIndividual ,
                                       <http://www.w3.org/2006/time#DurationDescription> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                              <http://www.w3.org/2006/time#nominalPosition> "days" ;
                              <http://www.w3.org/2006/time#numericDuration> 24 ;
                              <http://www.w3.org/2006/time#numericPosition> 0 ;
                              rdfs:label "Onset 8 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report8OnsetForIbuprofen
:Report8OnsetForIbuprofen rdf:type owl:NamedIndividual ,
                                   <http://www.w3.org/2006/time#DurationDescription> ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ibuprofen ;
                          <http://www.w3.org/2006/time#nominalPosition> "days" ;
                          <http://www.w3.org/2006/time#numericDuration> 24 ;
                          <http://www.w3.org/2006/time#numericPosition> 0 ;
                          rdfs:label "Onset 8 for ibuprofen" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report9
:Report9 rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#VigiBase_Report> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_free_text_reporting_element> :CommentsOnReport9 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_concomitant_drug> :furosemide ,
                                                                                    :paracetamol ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interacting_drug> :acetylsalicylicAcid ,
                                                                                    :ciprofloxacin ,
                                                                                    :enalapril ,
                                                                                    <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#amoxicillin/clavulanate> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_past_diagnosis> :chronicRenalFailure ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_patient> :Patient9 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_reported_drug_usage> :Usage_for_report_9_for_acetylsalicylic_acid ,
                                                                                       :Usage_for_report_9_for_ciprofloxacin ,
                                                                                       :Usage_for_report_9_for_enalapril ,
                                                                                       <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_9_for_amoxicillin/__clavulanate> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :Report9OnsetForCiprofloxacin ,
                                                                       <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report9Onsetforamoxicillin/clavulanate> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dechallenge_outcome> "negative - condition still applied" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_outcome_after_action> "death" ;
         rdfs:label "Report 9" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report9DosageForAcetylsalicylicAcid
:Report9DosageForAcetylsalicylicAcid rdf:type owl:NamedIndividual ,
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :acetylsalicylicAcid ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "300 mg" ;
                                     rdfs:label "Dosage for report 9 for acetylsalicylic acid" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report9DosageForCiprofloxacin
:Report9DosageForCiprofloxacin rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "1000 mg" ;
                               rdfs:label "Dosage for report 9 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report9DosageForEnalapril
:Report9DosageForEnalapril rdf:type owl:NamedIndividual ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "5 mg" ;
                           rdfs:label "Dosage for report 9 for Enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report9OnsetForCiprofloxacin
:Report9OnsetForCiprofloxacin rdf:type owl:NamedIndividual ,
                                       <http://www.w3.org/2006/time#DurationDescription> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                              <http://www.w3.org/2006/time#nominalPosition> "days" ;
                              <http://www.w3.org/2006/time#numericPosition> 4 ;
                              rdfs:label "Onset 9 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report9RouteOfAdministrationOfCiprofloxacin
:Report9RouteOfAdministrationOfCiprofloxacin rdf:type owl:NamedIndividual ,
                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                             rdfs:label "Route of administration of ciprofloxacin for report 9" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report9RouteOfAdministrationOfEnalapril
:Report9RouteOfAdministrationOfEnalapril rdf:type owl:NamedIndividual ,
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                         rdfs:label "Route of administration of Enalapril for report 9" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report9RouteOfAdministrationOfacetylsalicylicAcid
:Report9RouteOfAdministrationOfacetylsalicylicAcid rdf:type owl:NamedIndividual ,
                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :acetylsalicylicAcid ;
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                                   rdfs:label "Route of administration of acetylsalicylic acid for report 9" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report_13_route_of_administration_of_moxifloxacin
:Report_13_route_of_administration_of_moxifloxacin rdf:type owl:NamedIndividual ,
                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :moxifloxacin ;
                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "injected (intraveneous)" ;
                                                   rdfs:label "Report 13 route of administration of moxifloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report_16_route_of_administration_of_ciprofloxacin
:Report_16_route_of_administration_of_ciprofloxacin rdf:type owl:NamedIndividual ,
                                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                                    rdfs:label "Report 16 route of administration of ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report_16_route_of_administration_of_enalapril
:Report_16_route_of_administration_of_enalapril rdf:type owl:NamedIndividual ,
                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                                rdfs:label "Report 16 route of administration of enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report_16_route_of_administration_of_furosemide
:Report_16_route_of_administration_of_furosemide rdf:type owl:NamedIndividual ,
                                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :furosemide ;
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                                 rdfs:label "Report 16 route of administration of furosemide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report_16_route_of_administration_of_metamizole
:Report_16_route_of_administration_of_metamizole rdf:type owl:NamedIndividual ,
                                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :metamizole ;
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                                 rdfs:label "Report 16 route of administration of metamizole" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report_1_onset_for_metformin
:Report_1_onset_for_metformin rdf:type owl:NamedIndividual ,
                                       <http://www.w3.org/2006/time#DurationDescription> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :metformin ;
                              <http://www.w3.org/2006/time#nominalPosition> "months" ;
                              <http://www.w3.org/2006/time#numericPosition> 2 ;
                              rdfs:label "Onset 1 for metformin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ReportsFromGermany
:ReportsFromGermany rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_country> "http://dbpedia.org/resource/Germany" ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                    rdfs:label "Reports from Germany" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ReportsFromItaly
:ReportsFromItaly rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 2 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_country> "http://dbpedia.org/resource/Italy" ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                  rdfs:label "Reports from Italy" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ReportsFromSpain
:ReportsFromSpain rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 8 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_country> "http://dbpedia.org/resource/Spain" ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                  rdfs:label "Reports from Spain" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ReportsFromSweden
:ReportsFromSweden rdf:type owl:NamedIndividual ,
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 1 ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_country> "http://dbpedia.org/resource/Sweden" ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                   rdfs:label "Reports from Sweden" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ReportsFromSwitzerland
:ReportsFromSwitzerland rdf:type owl:NamedIndividual ,
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 2 ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_country> "http://dbpedia.org/resource/Switzerland" ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                        rdfs:label "Reports from Switzerland" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ReportsFromUnitedStates
:ReportsFromUnitedStates rdf:type owl:NamedIndividual ,
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 2 ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_country> "http://dbpedia.org/resource/United_States" ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                         rdfs:label "Reports from United States" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ReportsWithPositiveDechallenge
:ReportsWithPositiveDechallenge rdf:type owl:NamedIndividual ,
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 10 ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                rdfs:label "Reports with positive dechallenge" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Reports_in_Vigibase
:Reports_in_Vigibase rdf:type owl:NamedIndividual ,
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element> ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "As of 14 September 2016, VigiBase holds 16 reports that include ciprofloxacin and enalapril as suspect or interacting medicines and the MedDRA preferred term acute kidney injury. At the time of the signal detection screening the number of reports in this combination was 15 with an expected number of only two. The UMC measure of disproportionate reporting for drug-drug interactions (Ω)5 in VigiBase was 2.38 for Ω and 1.56 for the lower limit of the 95% credibility interval, Ω025. The 16 reports are from six countries, eight from Spain, two each from Italy, Switzerland and the United States (US), and one each from Germany and Sweden. No duplicates were detected. Table 1 shows the report details. There were eight males and eight females. The age range was 42 to 97 years with a median of 77.5 years. Patient characteristics included background chronic renal failure (CRF) in six patients. The indication for ciprofloxacin was urinary tract infection, cystitis or prostatitis for eight patients, four of whom had CRF. The time to onset of AKI from commencement of ciprofloxacin, recorded for 13 patients, was 0 to 43 days with a median of 5.5 days. Most patients had taken ciprofloxacin for two weeks or less. The route of administration was oral (13 patients) and the daily dose (six patients) 500 or 1000 mg. For enalapril, complete administration dates were recorded for six patients, four were long term users and two short term. The patients in the remaining reports were also long term users with the start date unknown. The route of administration was oral (13 patients). Daily doses (eight patients) were within the recommended range of 2.5 to 20 mg, with one outlier taking 50 mg. Assessment of individual case reports indicated a more likely alternative reason for AKI than a nephrotoxic effect of ciprofloxacin with enalapril in five patients (cases 12-16). These were dronedarone-related AKI (12), Lyell’s syndrome attributed to allopurinol or, less likely, ciprofloxacin (13), sepsis, pancytopenia and AKI with multiple antibiotics (14), AKI after multiple antibiotics for chemotherapy-related infection (15), a combined effect of metamizole, an NSAID, added to furosemide and enalapril two days prior to AKI onset with ciprofloxacin commenced on the day of AKI onset (16). Analysis of cases 1 to 11 in Table 1 indicated that in most patients although clinical conditions and a number of medicines were likely to have increased their risk of AKI, including ACE inhibitor-related AKI, the event did not occur until after a recent ciprofloxacin prescription lending weight to ciprofloxacin being the cause or a combined action of ciprofloxacin and enalapril. Enalapril was used long term in nine patients and ciprofloxacin use was short term in all eleven. Co-suspect medicines with enalapril and ciprofloxacin were recorded in 10 of the 11 reports and included NSAIDs (2, 8) and diuretics (3, 4, 5, 6, 11). All but one case was recorded as serious. At least five patients were admitted and four had prolonged hospital stays. After suspect medicines were stopped, ten patients recovered or were recovering and one died of cardiac failure eight days later. Three case reports (1, 7 and 10) are key reports. In case report 1 metformin was also suspect but it had been taken for two months and appears unlikely to have contributed. The patient in case report 7 had CRF and had taken bisoprolol, also suspect, for several months but renal impairment is not a labelled adverse drug reaction for this medicine. The patient recovered from AKI when all three medicines were discontinued. Patient 10 was also taking omeprazole, a known cause of interstitial nephritis, but he recovered when enalapril and ciprofloxacin were withdrawn and omeprazole continued. In five case reports, recent commencement of a diuretic (4, 5) or an NSAID (8) or recent rather than long term prescription of enalapril with a diuretic (11) may have triggered enalapril-related AKI or contributed when ciprofloxacin was added. One of these patients (4) and two others (2, 6) had diarrhoea and/or vomiting which may have had a similar effect. It is theoretically possible that in case report 3 renal tubular inhibition of methotrexate excretion by ciprofloxacin led to renal failure. An important feature of the 11 reports, with the exception of reports 1 and 10, is the patient characteristics that made them vulnerable to renal failure in association with enalapril use.3 Seven patients were taking diuretics and two were taking NSAIDs, three had diarrhoea and/or vomiting and four had cardiac conditions. Five patients were aged over 80 years and it is of note that four of these very elderly patients had two or more risk factors in addition to their age for enalapril-related renal failure. Therefore, if there is a ciprofloxacin effect when taken with enalapril, it is most evident in very vulnerable patients. If the AKI after ciprofloxacin was introduced could be entirely explained by infection or antibiotic-related diarrhoea, then disproportionate reporting would be expected for AKI with enalapril and other antibiotics. This disproportionality (Ω025 >0) was not observed with amoxicillin, azithromycin or flucloxacillin which, like ciprofloxacin, are used in an ambulatory setting (Table 2). The disproportionality measures do support a class effect of ACE inhibitors with ciprofloxacin (Ω025 >0). More evidence is needed to ascertain if there is a class effect for fluoroquinolones as there were few reports." ;
                     rdfs:label "Reports in Vigibase" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Reports_with_CRF
:Reports_with_CRF rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_past_diagnosis> :chronicRenalFailure ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 6 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                  rdfs:label "Reports with CRF" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Reports_with_daily_dose
:Reports_with_daily_dose rdf:type owl:NamedIndividual ,
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#1000_mg_dosage> ,
                                                                                          <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#500_mg_dosage> ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "the daily dose (six patients) 500 or 1000 mg" ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 6 ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                         rdfs:label "Reports with daily dose for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Reports_with_daily_dose_for_enalapril
:Reports_with_daily_dose_for_enalapril rdf:type owl:NamedIndividual ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#2.5_mg_dosage> ,
                                                                                                        <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#20_mg_dosage> ,
                                                                                                        <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#50_mg_dosage_for_enalapril> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Daily doses (eight patients) were within the recommended range of 2.5 to 20 mg, with one outlier taking 50 mg." ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 8 ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                       rdfs:label "Reports with daily dose for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Reports_with_indication
:Reports_with_indication rdf:type owl:NamedIndividual ,
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :cystitis ,
                                                                                                     :prostatitis ,
                                                                                                     :urinaryTractInfection ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 8 ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                         rdfs:label "Reports with indication" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Reports_with_oral_intake_form
:Reports_with_oral_intake_form rdf:type owl:NamedIndividual ,
                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :oral_intake_form_for_ciprofloxacin ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 13 ;
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                               rdfs:label "Reports with oral intake form for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Reports_with_oral_intake_form_for_enalapril
:Reports_with_oral_intake_form_for_enalapril rdf:type owl:NamedIndividual ,
                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :oral_intake_form_for_enalapril ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 13 ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                             rdfs:label "Reports with oral intake form for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Reports_with_time_to_onset_info
:Reports_with_time_to_onset_info rdf:type owl:NamedIndividual ,
                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Reports_group> ;
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_subgroup_of> :OverallReportsInVigibase ;
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#time_to_onset> :time_to_onset_info ;
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_count> 13 ;
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                 rdfs:label "Reports with time to onset info" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Uppsala_Monitoring_Centre
:Uppsala_Monitoring_Centre rdf:type owl:NamedIndividual ,
                                    <http://www.w3.org/ns/prov#Organization> ;
                           rdfs:label "Uppsala Monitoring Centre" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_10_for_ciprofloxacin
:Usage_for_report_10_for_ciprofloxacin rdf:type owl:NamedIndividual ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :urinaryTractInfection ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report10DosageForCiprofloxacin ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report10DosageForCiprofloxacin ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                       rdfs:label "Usage for report 10 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_10_for_enalapril
:Usage_for_report_10_for_enalapril rdf:type owl:NamedIndividual ,
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :hypertension ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report10RouteOfAdministrationOfEnalapril ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report10DosageForEnalapril ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                   rdfs:label "Usage for report 10 for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_11_for_ciprofloxacin
:Usage_for_report_11_for_ciprofloxacin rdf:type owl:NamedIndividual ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :bronchopneumonia ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report11RouteOfAdministrationOfCiprofloxacin ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report11DosageForCiprofloxacin ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                       rdfs:label "Usage for report 11 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_11_for_enalapril
:Usage_for_report_11_for_enalapril rdf:type owl:NamedIndividual ,
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :heartDiseaseComplications ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report11RouteOfAdministrationOfEnalapril ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report11DosageForEnalapril ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                   rdfs:label "Usage for report 11 for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_11_for_furosemide
:Usage_for_report_11_for_furosemide rdf:type owl:NamedIndividual ,
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :heartDiseaseComplications ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report11RouteOfAdministrationOfFurosemide ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report11DosageForFurosemide ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :furosemide ;
                                    rdfs:label "Usage for report 11 for furosemide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_12_for_acenocoumarol
:Usage_for_report_12_for_acenocoumarol rdf:type owl:NamedIndividual ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :atrialFibrillation ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report12RouteOfAdministrationOfAcenocoumarol ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :acenocoumarol ;
                                       rdfs:label "Usage for report 12 for acenocoumarol" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_12_for_ciprofloxacin
:Usage_for_report_12_for_ciprofloxacin rdf:type owl:NamedIndividual ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :cystitis ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report12RouteOfAdministrationOfCiprofloxacin ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report12DosageForCiprofloxacin ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                       rdfs:label "Usage for report 12 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_12_for_dronedarone
:Usage_for_report_12_for_dronedarone rdf:type owl:NamedIndividual ,
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :atrialFibrillation ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report12RouteOfAdministrationOfDronedarone ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report12DosageForDronedarone ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :dronedarone ;
                                     rdfs:label "Usage for report 12 for dronedarone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_12_for_enalapril
:Usage_for_report_12_for_enalapril rdf:type owl:NamedIndividual ,
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :hypertension ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report12RouteOfAdministrationOfEnalapril ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report12DosageForEnalapril ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                   rdfs:label "Usage for report 12 for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_12_for_sitagliptin
:Usage_for_report_12_for_sitagliptin rdf:type owl:NamedIndividual ,
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :type2DiabetesMellitus ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report12RouteOfAdministrationOfSitagliptin ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :sitagliptin ;
                                     rdfs:label "Usage for report 12 for sitagliptin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_13_for_allopurinol
:Usage_for_report_13_for_allopurinol rdf:type owl:NamedIndividual ,
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report13RouteOfAdministrationOfAllopurinol ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report13DosageForAllopurinol ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :allopurinol ;
                                     rdfs:label "Usage for report 13 for allopurinol" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_13_for_ciprofloxacin
:Usage_for_report_13_for_ciprofloxacin rdf:type owl:NamedIndividual ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :infectedScar ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report13RouteOfAdministrationOfCiprofloxacin ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                       rdfs:label "Usage for report 13 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_13_for_enalapril
:Usage_for_report_13_for_enalapril rdf:type owl:NamedIndividual ,
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report13RouteOfAdministrationOfEnalapril ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report13DosageForEnalapril ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                   rdfs:label "Usage for report 13 for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_13_for_moxifloxacin
:Usage_for_report_13_for_moxifloxacin rdf:type owl:NamedIndividual ,
                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report_13_route_of_administration_of_moxifloxacin ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :moxifloxacin ;
                                      rdfs:label "Usage for report 13 for moxifloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_14_for_ceftriaxone
:Usage_for_report_14_for_ceftriaxone rdf:type owl:NamedIndividual ,
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :diabeticFoot ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report14RouteOfAdministrationOfCeftriaxone ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ceftriaxone ;
                                     rdfs:label "Usage for report 14 for ceftriaxone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_14_for_telavancin
:Usage_for_report_14_for_telavancin rdf:type owl:NamedIndividual ,
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :osteomyelitis ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report14RouteOfAdministrationOfTelavancin ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :telavancin ;
                                    rdfs:label "Usage for report 14 for telavancin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_15_for_carboplatin
:Usage_for_report_15_for_carboplatin rdf:type owl:NamedIndividual ,
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :non-smallCellLungCancer ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report15RouteOfAdministrationOfCarboplatin ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report15DosageForCarboplatin ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :carboplatin ;
                                     rdfs:label "Usage for report 15 for carboplatin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_15_for_ciprofloxacin
:Usage_for_report_15_for_ciprofloxacin rdf:type owl:NamedIndividual ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :pneumonia ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                       rdfs:label "Usage for report 15 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_15_for_enalapril
:Usage_for_report_15_for_enalapril rdf:type owl:NamedIndividual ,
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :hypertension ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                   rdfs:label "Usage for report 15 for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_15_for_oxacillin
:Usage_for_report_15_for_oxacillin rdf:type owl:NamedIndividual ,
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :pneumonia ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :oxacillin ;
                                   rdfs:label "Usage for report 15 for oxacillin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_15_for_paclitaxel
:Usage_for_report_15_for_paclitaxel rdf:type owl:NamedIndividual ,
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :non-smallCellLungCancer ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report15RouteOfAdministrationOfPaclitaxel ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report15DosageForPaclitaxel ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :paclitaxel ;
                                    rdfs:label "Usage for report 15 for paclitaxel" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_15_for_vancomycin
:Usage_for_report_15_for_vancomycin rdf:type owl:NamedIndividual ,
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :pneumonia ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :vancomycin ;
                                    rdfs:label "Usage for report 15 for vancomycin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_16_for_ciprofloxacin
:Usage_for_report_16_for_ciprofloxacin rdf:type owl:NamedIndividual ,
                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :urinaryTractInfection ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report_16_route_of_administration_of_ciprofloxacin ;
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                       rdfs:label "Usage for report 16 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_16_for_enalapril
:Usage_for_report_16_for_enalapril rdf:type owl:NamedIndividual ,
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :hypertension ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report_16_route_of_administration_of_enalapril ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                   rdfs:label "Usage for report 16 for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_16_for_furosemide
:Usage_for_report_16_for_furosemide rdf:type owl:NamedIndividual ,
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :cardiacFailure ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report_16_route_of_administration_of_furosemide ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :furosemide ;
                                    rdfs:label "Usage for report 16 for furosemide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_16_for_metamizole
:Usage_for_report_16_for_metamizole rdf:type owl:NamedIndividual ,
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :osteoarthritis ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report_16_route_of_administration_of_metamizole ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :metamizole ;
                                    rdfs:label "Usage for report 16 for metamizole" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_1_for_ciprofloxacin
:Usage_for_report_1_for_ciprofloxacin rdf:type owl:NamedIndividual ,
                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :urinaryTractInfection ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report1RouteOfAdministrationOfciprofloxacin ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report1DosageForCiprofloxacin ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                      rdfs:label "Usage for report 1 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_1_for_enalapril
:Usage_for_report_1_for_enalapril rdf:type owl:NamedIndividual ,
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :hypertension ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report1RouteOfAdministrationOfEnalapril ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report1DosageForEnalapril ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                  rdfs:label "Usage for report 1 for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_1_for_metformin
:Usage_for_report_1_for_metformin rdf:type owl:NamedIndividual ,
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :type2DiabetesMellitus ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report1RouteOfAdministrationOfMetformin ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report1DosageForMetformin ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :metformin ;
                                  rdfs:label "Usage for report 1 for metformin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_2_for_ciprofloxacin
:Usage_for_report_2_for_ciprofloxacin rdf:type owl:NamedIndividual ,
                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :urinaryTractInfection ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report2RouteOfAdministrationOfCiprofloxacin ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                      rdfs:label "Usage for report 2 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_2_for_enalapril
:Usage_for_report_2_for_enalapril rdf:type owl:NamedIndividual ,
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :hypertension ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report2RouteOfAdministrationOfEnalapril ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                  rdfs:label "Usage for report 2 for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_2_for_ibuprofen
:Usage_for_report_2_for_ibuprofen rdf:type owl:NamedIndividual ,
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report2RouteOfAdministrationOfIbuprofen ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ibuprofen ;
                                  rdfs:label "Usage for report 2 for ibuprofen" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_2_for_pravastatin
:Usage_for_report_2_for_pravastatin rdf:type owl:NamedIndividual ,
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :hyperlipidaemia ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report2RouteOfAdministrationOfpravastatin ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :pravastatin ;
                                    rdfs:label "Usage for report 2 for pravastatin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_3_for_ciprofloxacin
:Usage_for_report_3_for_ciprofloxacin rdf:type owl:NamedIndividual ,
                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report3RouteOfAdministrationOfCiprofloxacin ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                      rdfs:label "Usage for report 3 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_3_for_enalapril
:Usage_for_report_3_for_enalapril rdf:type owl:NamedIndividual ,
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report3RouteOfAdministrationOfEnalapril ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report3DosageForEnalapril ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                  rdfs:label "Usage for report 3 for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_3_for_methotrexate
:Usage_for_report_3_for_methotrexate rdf:type owl:NamedIndividual ,
                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report3RouteOfAdministrationOfmethotrexate ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report3DosageForMethotrexate ;
                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :methotrexate ;
                                     rdfs:label "Usage for report 3 for methotrexate" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_3_for_metolazone
:Usage_for_report_3_for_metolazone rdf:type owl:NamedIndividual ,
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report3RouteOfAdministrationOfMetolazone ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report3DosageForMetolazone ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :metolazone ;
                                   rdfs:label "Usage for report 3 for metolazone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_3_for_torasemide
:Usage_for_report_3_for_torasemide rdf:type owl:NamedIndividual ,
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report3RouteOfAdministrationOfTorasemide ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report3DosageForTorasemide ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :torasemide ;
                                   rdfs:label "Usage for report 3 for torasemide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_4_for_ciprofloxacin
:Usage_for_report_4_for_ciprofloxacin rdf:type owl:NamedIndividual ,
                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Bronchitis ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report4RouteOfAdministrationOfCiprofloxacin ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                      rdfs:label "Usage for report 4 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_4_for_enalapril
:Usage_for_report_4_for_enalapril rdf:type owl:NamedIndividual ,
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :hypertension ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report5RouteOfAdministrationOfEnalapril ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report4DosageForEnalapril ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                  rdfs:label "Usage for report 4 for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_4_for_furosemide
:Usage_for_report_4_for_furosemide rdf:type owl:NamedIndividual ,
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :cardiacDecompensation ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report4RouteOfAdministrationOfFurosemide ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :furosemide ;
                                   rdfs:label "Usage for report 4 for furosemide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_5_for_ciprofloxacin
:Usage_for_report_5_for_ciprofloxacin rdf:type owl:NamedIndividual ,
                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :urinaryTractInfection ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report5RouteOfAdministrationOfCiprofloxacin ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                      rdfs:label "Usage for report 5 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_5_for_enalapril
:Usage_for_report_5_for_enalapril rdf:type owl:NamedIndividual ,
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :hypertension ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report5RouteOfAdministrationOfEnalapril ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                  rdfs:label "Usage for report 5 for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_5_for_furosemide
:Usage_for_report_5_for_furosemide rdf:type owl:NamedIndividual ,
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :hypertension ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report5RouteOfAdministrationOffurosemide ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :furosemide ;
                                   rdfs:label "Usage for report 5 for furosemide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_6_for_ciprofloxacin
:Usage_for_report_6_for_ciprofloxacin rdf:type owl:NamedIndividual ,
                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :Bronchitis ,
                                                                                                                  :gastroenteritis ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report6RouteOfAdministrationOfCiprofloxacin ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report6DosageForCiprofloxacin ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                      rdfs:label "Usage for report 6 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_6_for_enalapril
:Usage_for_report_6_for_enalapril rdf:type owl:NamedIndividual ,
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :hypertension ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report6RouteOfAdministrationOfEnalapril ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report6DosageForEnalapril ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                  rdfs:label "Usage for report 6 for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_6_for_hydrochlorothiazide
:Usage_for_report_6_for_hydrochlorothiazide rdf:type owl:NamedIndividual ,
                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :hypertension ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report6RouteOfAdministrationOfHydrochlorothiazide ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report6DosageForHydrochlorothiazide ;
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :hydrochlorothiazide ;
                                            rdfs:label "Usage for report 6 for hydrochlorothiazide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_7_for_bisoprolol
:Usage_for_report_7_for_bisoprolol rdf:type owl:NamedIndividual ,
                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report7RouteOfAdministrationOfBisoprolol ;
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :bisoprolol ;
                                   rdfs:label "Usage for report 7 for bisoprolol" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_7_for_ciprofloxacin
:Usage_for_report_7_for_ciprofloxacin rdf:type owl:NamedIndividual ,
                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :prostatitis ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report7RouteOfAdministrationOfCiprofloxacin ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                      rdfs:label "Usage for report 7 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_7_for_enalapril
:Usage_for_report_7_for_enalapril rdf:type owl:NamedIndividual ,
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :hypertension ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report7RouteOfAdministrationOfEnalapril ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                  rdfs:label "Usage for report 7 for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_8_for_ciprofloxacin
:Usage_for_report_8_for_ciprofloxacin rdf:type owl:NamedIndividual ,
                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :urinaryTractInfection ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                      rdfs:label "Usage for report 8 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_8_for_enalapril
:Usage_for_report_8_for_enalapril rdf:type owl:NamedIndividual ,
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :hypertension ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                  rdfs:label "Usage for report 8 for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_8_for_ibuprofen
:Usage_for_report_8_for_ibuprofen rdf:type owl:NamedIndividual ,
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :trouble_with_knee ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ibuprofen ;
                                  rdfs:label "Usage for report 8 for ibuprofen" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_9_for_acetylsalicylic_acid
:Usage_for_report_9_for_acetylsalicylic_acid rdf:type owl:NamedIndividual ,
                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :cardiomyopathy ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report9RouteOfAdministrationOfacetylsalicylicAcid ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report9DosageForAcetylsalicylicAcid ;
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :acetylsalicylicAcid ;
                                             rdfs:label "Usage for report 9 for acetylsalicylic acid" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_9_for_ciprofloxacin
:Usage_for_report_9_for_ciprofloxacin rdf:type owl:NamedIndividual ,
                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :respiratoryInfection ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report9RouteOfAdministrationOfCiprofloxacin ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report9DosageForCiprofloxacin ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                      rdfs:label "Usage for report 9 for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_9_for_enalapril
:Usage_for_report_9_for_enalapril rdf:type owl:NamedIndividual ,
                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :cardiomyopathy ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> :Report9RouteOfAdministrationOfEnalapril ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dosage> :Report9DosageForEnalapril ;
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                  rdfs:label "Usage for report 9 for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#acenocoumarol
:acenocoumarol rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "B01AA07" ;
               rdfs:label "acenocoumarol" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#acetylsalicylicAcid
:acetylsalicylicAcid rdf:type owl:NamedIndividual ,
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "B01AC06" ;
                     rdfs:label "acetylsalicylic Acid" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#acuteKidneyInjury
:acuteKidneyInjury rdf:type owl:NamedIndividual ,
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "N17.9" ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10069339 ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Acute kidney injury" ;
                   rdfs:label "acute kidney injury" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#acute_bronchitis
:acute_bronchitis rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10000687 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Acute bronchitis" ;
                  rdfs:label "acute bronchitis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#adenocarcinoma
:adenocarcinoma rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10001141 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Adenocarcinoma" ;
                rdfs:label "adenocarcinoma" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#allopurinol
:allopurinol rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "M04AA01 " ;
             rdfs:label "allopurinol" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#alprazolam
:alprazolam rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N05BA12" ;
            rdfs:label "alprazolam" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#amoxicillin
:amoxicillin rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J01CA04" ;
             rdfs:label "amoxicillin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#antibiotics
:antibiotics rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#DrugClass> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J01" ;
             rdfs:label "antibiotics" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#atrialFibrillation
:atrialFibrillation rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "I48" ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10003658 ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Atrial fibrillation" ;
                    rdfs:label "atrial fibrillation" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#azithromycin
:azithromycin rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J01FA10" ;
              rdfs:label "azithromycin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#bisoprolol
:bisoprolol rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C07AB07" ;
            rdfs:label "bisoprolol" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#bladder_cancer
:bladder_cancer rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10005003 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Bladder cancer" ;
                rdfs:label "bladder cancer" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#bloodGlucoseUncontrolled
:bloodGlucoseUncontrolled rdf:type owl:NamedIndividual ,
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R73.09" ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10005554 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Blood glucose abnormal" ;
                          rdfs:label "blood glucose uncontrolled" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#bloodUreaNitrogen
:bloodUreaNitrogen rdf:type owl:NamedIndividual ,
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10005852 ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Blood urea nitrogen" ;
                   rdfs:label "blood urea nitrogen" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#bronchopneumonia
:bronchopneumonia rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "J18.0" ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10035664 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Pneumonia" ;
                  rdfs:label "bronchopneumonia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#carboplatin
:carboplatin rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "L01XA02 " ;
             rdfs:label "carboplatin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#cardiacDecompensation
:cardiacDecompensation rdf:type owl:NamedIndividual ,
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "I50.9" ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10007554 ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Cardiac failure" ;
                       rdfs:label "cardiac decompensation" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#cardiacFailure
:cardiacFailure rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> " " ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10007554 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Cardiac failure" ;
                rdfs:label "cardiac failure" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#cardiomyopathy
:cardiomyopathy rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "I42.9" ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10007636 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Cardiomyopathy" ;
                rdfs:label "cardiomyopathy" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#cefepime
:cefepime rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J01DE01" ;
          rdfs:label "cefepime" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ceftriaxone
:ceftriaxone rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J01DD04 " ;
             rdfs:label "ceftriaxone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#cellulitis
:cellulitis rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "L03.90" ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10007882 ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Cellulitis" ;
            rdfs:label "cellulitis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#chronicRenalFailure
:chronicRenalFailure rdf:type owl:NamedIndividual ,
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "N18.9" ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10064848 ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Chronic kidney disease" ;
                     rdfs:label "chronic renal failure" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ciprofloxacin
:ciprofloxacin rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_mechanism> :Mechanism_of_Ciprofloxacin ,
                                                                             :interaction_between_enalapril_and_ciprofloxacin ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J01MA02" ;
               rdfs:label "ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ciprofloxacin_and_AKI
:ciprofloxacin_and_AKI rdf:type owl:NamedIndividual ,
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Warning_Information> ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ,
                                                                                                :interstitialNephritis ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                       mp:references :Ref.1 ,
                                     :Ref.2 ;
                       rdfs:label "ciprofloxacin and AKI" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ciprofloxacin_and_diarrhoea
:ciprofloxacin_and_diarrhoea rdf:type owl:NamedIndividual ,
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Warning_Information> ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :dehydration ,
                                                                                                      :diarrhoea ;
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                             rdfs:label "ciprofloxacin and diarrhoea" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ciprofloxacin_and_elalapril_interaction
:ciprofloxacin_and_elalapril_interaction rdf:type owl:NamedIndividual ,
                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug-Drug_interaction> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interacting_drug> :ciprofloxacin ,
                                                                                                                    :enalapril ;
                                         rdfs:label "ciprofloxacin and elalapril interaction" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ciprofloxacin_and_other_ADRs
:ciprofloxacin_and_other_ADRs rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Warning_Information> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :bloodUreaNitrogen ,
                                                                                                       :crystalluria ,
                                                                                                       :increasedSerumCreatinine ,
                                                                                                       :macrohaematuria ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                              mp:references :Ref.3 ;
                              rdfs:label "ciprofloxacin and other ADRs" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#clonazepam
:clonazepam rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N03AE01" ;
            rdfs:label "clonazepam " .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#colecalciferol
:colecalciferol rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A11CC05" ;
                rdfs:label "colecalciferol" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#copd
:copd rdf:type owl:NamedIndividual ,
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10009033 ;
      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Chronic obstructive pulmonary disease" ;
      rdfs:label "copd" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#crystalluria
:crystalluria rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R82.9" ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10011509 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Crystalluria" ;
              rdfs:label "crystalluria" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#cystitis
:cystitis rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "N30.90 " ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10011781 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "cystitis" ;
          rdfs:label "cystitis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#deflazacort
:deflazacort rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "H02AB13" ;
             rdfs:label "deflazacort" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#dehydration
:dehydration rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> " E86.0 " ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10012174 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Dehydration" ;
             rdfs:label "dehydration" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#deviceRelatedInfection
:deviceRelatedInfection rdf:type owl:NamedIndividual ,
                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "T85.79XA" ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10064687 ;
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Device related infection" ;
                        rdfs:label "device related infection" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#diabeticFoot
:diabeticFoot rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "E11.621" ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10060734 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Diabetic foot" ;
              rdfs:label "diabetic foot" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#diarrhoea
:diarrhoea rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> " R19.7" ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10012735 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Diarrhoea" ;
           rdfs:label "diarrhoea" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#digoxin
:digoxin rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C01AA05 " ;
         rdfs:label "digoxin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#dizziness
:dizziness rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10013573 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Dizziness" ;
           rdfs:label "dizziness" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#dronedarone
:dronedarone rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C01BD07 " ;
             rdfs:label "dronedarone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#dyslipidaemia
:dyslipidaemia rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10058108 ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Dyslipidaemia" ;
               rdfs:label "dyslipidaemia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#enalapril
:enalapril rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_mechanism> :Mechanism_of_Enalapril ,
                                                                         :Mechanism_of_renal_toxicity ,
                                                                         :interaction_between_enalapril_and_ciprofloxacin ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C09AA02 " ;
           rdfs:label "enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#flucloxacillin
:flucloxacillin rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J01CF05" ;
                rdfs:label "flucloxacillin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#fluroquinolones
:fluroquinolones rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#DrugClass> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J01MA" ;
                 rdfs:label "fluoroquinolones" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#folic
:folic rdf:type owl:NamedIndividual ,
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "B03BB01" ;
       rdfs:label "folic" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#furosemide
:furosemide rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C03CA01 " ;
            rdfs:label "furosemide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#gastroenteritis
:gastroenteritis rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "K52.9" ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10017888 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Gastroenteritis" ;
                 rdfs:label "gastroenteritis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#glaucoma
:glaucoma rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10018304 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Glaucoma" ;
          rdfs:label "glaucoma" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#glimepiride
:glimepiride rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A10BB12" ;
             rdfs:label "glimepiride" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#glycerylTrinitrate
:glycerylTrinitrate rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C01DA02 " ;
                    rdfs:label "glyceryl trinitrate" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#gout
:gout rdf:type owl:NamedIndividual ,
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10018627 ;
      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Gout" ;
      rdfs:label "gout" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#heartDiseaseComplications
:heartDiseaseComplications rdf:type owl:NamedIndividual ,
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                           rdfs:label "heart disease complications" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#hydrochlorothiazide
:hydrochlorothiazide rdf:type owl:NamedIndividual ,
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C03AA03" ;
                     rdfs:label "hydrochlorotheiazide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#hyperlipidaemia
:hyperlipidaemia rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "E78.5" ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10062060 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Hyperlipidaemia" ;
                 rdfs:label "hyperlipidaemia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#hypertension
:hypertension rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "I50" ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10020772 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Hypertension" ;
              rdfs:label "hypertension" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#hypertensiveHeartDisease
:hypertensiveHeartDisease rdf:type owl:NamedIndividual ,
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "I11.0" ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10020823 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Hypertensive heart disease" ;
                          rdfs:label "hypertensive heart disease" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#hyperuricaemia
:hyperuricaemia rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10020903 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Hyperuricaemia" ;
                rdfs:label "hyperuricaemia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#hyponatraemia
:hyponatraemia rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "E87.1" ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10021036 ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Hyponatraemia" ;
               rdfs:label "hyponatraemia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#hypotension
:hypotension rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "I95" ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10021097 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "hypotension" ;
             rdfs:label "hypotension" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#hypoxia
:hypoxia rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "P21.9" ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10021143 ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Hypoxia" ;
         rdfs:label "hypoxia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ibuprofen
:ibuprofen rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C01EB16" ;
           rdfs:label "ibuprofen" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#increasedSerumCreatinine
:increasedSerumCreatinine rdf:type owl:NamedIndividual ,
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R79.89" ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10005483 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Blood creatinine increased" ;
                          rdfs:label "increased serum creatinine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#infectedScar
:infectedScar rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "L08.9" ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10040872 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Skin infection" ;
              rdfs:label "infected scar" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#insulin
:insulin rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A10AD01 " ;
         rdfs:label "insulin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#interaction_between_enalapril_and_ciprofloxacin
:interaction_between_enalapril_and_ciprofloxacin rdf:type owl:NamedIndividual ,
                                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect_Mechanism> ;
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "A potential mechanism for the observed interaction has not been identified. Most of the published reports summarised by Lomaestro indicate acute interstitial nephritis as the underlying cause of AKI with fluoroquinolones.2 This is rare although the estimated incidence of 1 in 1,526 in the case control study of hospital admissions is likely to be an underestimate as patients may have been admitted with an alternative 2,primary diagnosis or recovered before needing admission. Interstitial nephritis or other pathology due to a fluoroquinolone could be a trigger for ACE inhibitor-related AKI or more severe AKI leading to admission." ;
                                                 rdfs:label "interaction between enalapril and ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#interstitialNephritis
:interstitialNephritis rdf:type owl:NamedIndividual ,
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "N12" ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10029134 ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Nephritis interstitial" ;
                       rdfs:label "interstitial nephritis " .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#introduction
:introduction rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Introduction> ;
              mp:references :Ref.1 ,
                            :Ref.2 ,
                            :Ref.3 ,
                            :Ref.4 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "A signal detection screening focusing on drugdrug interactions identified disproportionate reporting of a combination of ciprofloxacin, enalapril and acute kidney injury (AKI) in VigiBase, the WHO global database of individual case safety reports. A range of pre-renal, renal and post-renal clinical conditions can lead to AKI. Drugs can be involved at any of these levels and so may cause conditions leading to pre-renal injury by volume depletion e.g. through haemorrhage or dehydration, or through a direct effect on glomerular arteriolar pressures. Drug-induced direct renal toxicity e.g. due to interstitial nephritis or acute tubular necrosis is well-recognised. Promotion of renal stone formation can lead to post-renal obstruction and AKI. Ciprofloxacin is a broad spectrum fluoroquinolone antibiotic. It has been estimated that about 1 in 1,500 patients develop AKI after taking ciprofloxacin.1 The underlying pathology identified through published case histories was interstitial nephritis in most patients.2 There have also been reports of increased serum creatinine and blood urea nitrogen and, more rarely, crystalluria and macrohaematuria.3 As a broad spectrum antibiotic, it can also cause diarrhoea which may lead to dehydration and AKI in susceptible patients. Enalapril is an angiotensin converting enzyme (ACE) inhibitor used to reduce blood pressure and treat cardiac failure. ACE inhibitors decrease the production of angiotensin II, a substance which causes post-glomerular arteriolar constriction thus maintaining glomerular capillary filtration. Usually pre-glomerular arteriolar pressures are high enough for adequate filtration in the presence of ACE inhibition but drugs and clinical conditions that affect renal blood flow and pre-glomerular arteriolar pressures may trigger renal failure in patients taking ACE inhibitors. These include concomitant use of loop, thiazide or potassium-sparing diuretics, and prostaglandin inhibitors (NSAIDs), renal artery stenosis, renal transplant, old age, ischaemic heart disease and congestive heart failure, sodium restriction, sodium depletion, volume depletion, hypotension and gastrointestinal fluid loss.4" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ipratropium
:ipratropium rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "R03BB01" ;
             rdfs:label "ipratropium" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#key_reports
:key_reports rdf:type owl:NamedIndividual ,
                      <http://purl.obolibrary.org/obo/OAE_0001197> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Three case reports (1, 7 and 10) are key reports. In case report 1 metformin was also suspect but it had been taken for two months and appears unlikely to have contributed. The patient in case report 7 had CRF and had taken bisoprolol, also suspect, for several months but renal impairment is not a labelled adverse drug reaction for this medicine. The patient recovered from AKI when all three medicines were discontinued. Patient 10 was also taking omeprazole, a known cause of interstitial nephritis, but he recovered when enalapril and ciprofloxacin were withdrawn and omeprazole continued." ;
             rdfs:label "key reports" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#klebsiellaInfection
:klebsiellaInfection rdf:type owl:NamedIndividual ,
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "B96.1 " ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10061259 ;
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Klebsiella infection" ;
                     rdfs:label "klebsiella infection" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#levofloxacin
:levofloxacin rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J01MA12" ;
              rdfs:label "levofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#lisinopril
:lisinopril rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C09AA03" ;
            rdfs:label "lisinopril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#lomaestro_review
:lomaestro_review rdf:type owl:NamedIndividual ,
                           <http://purl.obolibrary.org/obo/OAE_0001197> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :nephrotoxicity ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_class> :fluroquinolones ;
                  mp:references :Ref.2 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Lomaestro2 conducted a literature review to ascertain the incidence and characteristics of fluoroquinolone-related nephrotoxicity. Publications were mostly case reports and the incidence was difficult to estimate. Nearly all of the 44 reports of acute renal failure identified involved patients aged over 50 years. The most frequently reported pathology was acute interstitial nephritis. A high proportion of patients were taking other nephrotoxic medicines, particularly chemotherapeutic and immunosuppressive agents. One patient was taking an ACE inhibitor." ;
                  rdfs:label "lomaestro review" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#lorazepam
:lorazepam rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N05BA06" ;
           rdfs:label "lorazepam" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#macrohaematuria
:macrohaematuria rdf:type owl:NamedIndividual ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ,
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R31.0" ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10059802 ;
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Macroscopic haematuria" ;
                 rdfs:label "macrohaematuria" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#metamizole
:metamizole rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N02BB02 " ;
            rdfs:label "metamizole" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#metformin
:metformin rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A10BA02 " ;
           rdfs:label "metformin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#methotrexate
:methotrexate rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "L01BA01" ;
              rdfs:label "methotrexate" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#metolazone
:metolazone rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C03BA08" ;
            rdfs:label "metolazone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#mirtazapine
:mirtazapine rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N06AX11" ;
             rdfs:label "mirtazapine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#more_likely_alternative_reasons_for_AKI
:more_likely_alternative_reasons_for_AKI rdf:type owl:NamedIndividual ,
                                                  <http://purl.obolibrary.org/obo/OAE_0001182> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ,
                                                                                                                  :pancytopenia ,
                                                                                                                  :sepsis ,
                                                                                                                  <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#lyell'sSyndrome> ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_class> :antibiotics ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :dronedarone ,
                                                                                                        :furosemide ,
                                                                                                        :metamizole ;
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "Assessment of individual case reports indicated a more likely alternative reason for AKI than a nephrotoxic effect of ciprofloxacin with enalapril in five patients (cases 12-16). These were dronedarone-related AKI (12), Lyell’s syndrome attributed to allopurinol or, less likely, ciprofloxacin (13), sepsis, pancytopenia and AKI with multiple antibiotics (14), AKI after multiple antibiotics for chemotherapy-related infection (15), a combined effect of metamizole, an NSAID, added to furosemide and enalapril two days prior to AKI onset with ciprofloxacin commenced on the day of AKI onset (16)." ;
                                         rdfs:label "more likely alternative reasons for AKI" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#moxifloxacin
:moxifloxacin rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J01MA14 " ;
              rdfs:label "moxifloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#nausea
:nausea rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10028813 ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Nausea" ;
        rdfs:label "nausea" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#nephrotoxicity
:nephrotoxicity rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10067571 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Nephrotoxicity" ;
                rdfs:label "nephrotoxicity" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#nested_case_control_study
:nested_case_control_study rdf:type owl:NamedIndividual ,
                                    <http://purl.obolibrary.org/obo/OAE_0001197> ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_class> :fluroquinolones ;
                           mp:references :Ref.1 ;
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "A nested case-control study examined the risk of AKI with the use of fluoroquinolones in a cohort of men aged between 40 and 85 years in the US IMS Lifelink Heath Plan Claims Database.1 The number of cases and controls was 1,292 and 12,651 respectively. After adjusting for fluoroquinolone indication, which included genitourinary infections, diseases associated with AKI including congestive heart failure and diabetes, and potentially nephrotoxic medicines with high use i.e. NSAIDs, loop diuretics and renin-angiotensin blockers, the rate ratio (RR) of AKI with current fluoroquinolone use was 2.18 (95% confidence interval (CI) 1.74 – 2.73), which equated to an absolute increase in AKI of 6.5/10,000 person-years or one additional case per 1,529 patients given a fluoroquinolone. This finding was supported by the results of a case-time-control analysis in the same cohort in which within-patient comparisons were made of drug exposures. The findings were similar whether or not patients had genitourinary infection or chronic kidney disease. The highest RR for the individual fluoroquinolones was for ciprofloxacin (2.76, 95% CI 2.03 – 3.76). This increased risk was not found with amoxicillin and azithromycin suggesting infection was not an alternative explanation. The authors also hypothesised interactions between fluoroquinolones and NSAIDs, loop diuretics or renin-angiotensin system blockers (ACE inhibitors or angiotensin-receptor blockers) but only had sufficient power to examine the renin-angiotensin system blockers. There was no increase in risk of AKI with renin-angiotensin system blocker treatment alone (RR 1.00, 95% CI 0.84 – 1.18) but the combined use of these medicines with fluoroquinolones increased the RR for AKI from 2.18 for fluoroquinolones alone to 4.46 (95% CI 2.84 – 6.99) which was greater than the additive risk. The lack of increased risk of AKI with renin-angiotensin system blockers alone was unexpected. The authors considered that physician monitoring of serum creatinine levels, particularly after starting renin-angiotensin blockers may be one explanation." ;
                           rdfs:label "nested case control study" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#non-smallCellLungCancer
:non-smallCellLungCancer rdf:type owl:NamedIndividual ,
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> " C34.90" ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10061873 ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Non-small cell lung cancer" ;
                         rdfs:label "non-small cell lung cancer" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#omeprazole
:omeprazole rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A02BC01" ;
            rdfs:label "omeprazole" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#one_day_interval
:one_day_interval rdf:type owl:NamedIndividual ,
                           <http://www.w3.org/2006/time#DurationDescription> ;
                  <http://www.w3.org/2006/time#nominalPosition> "days" ;
                  <http://www.w3.org/2006/time#numericPosition> 1 ;
                  rdfs:label "one day interval" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#one_week_interval
:one_week_interval rdf:type owl:NamedIndividual ,
                            <http://www.w3.org/2006/time#DurationDescription> ;
                   <http://www.w3.org/2006/time#nominalPosition> "weeks" ;
                   <http://www.w3.org/2006/time#numericPosition> 1 ;
                   rdfs:label "one week interval" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#oral_intake_form_for_ciprofloxacin
:oral_intake_form_for_ciprofloxacin rdf:type owl:NamedIndividual ,
                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                    rdfs:label "oral intake form for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#oral_intake_form_for_enalapril
:oral_intake_form_for_enalapril rdf:type owl:NamedIndividual ,
                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                rdfs:label "oral intake form for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#osteoarthritis
:osteoarthritis rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "M19.90" ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10031161 ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Osteoarthritis" ;
                rdfs:label "osteoarthritis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#osteomyelitis
:osteomyelitis rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "M86" ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10031252 ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Osteomyelitis" ;
               rdfs:label "osteomyelitis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#oxacillin
:oxacillin rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J01CF04 " ;
           rdfs:label "oxacillin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#oxazepam
:oxazepam rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N05BA04" ;
          rdfs:label "oxazepam" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#paclitaxel
:paclitaxel rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "L01CD01 " ;
            rdfs:label "paclitaxel" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#pancytopenia
:pancytopenia rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "D61.81" ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10033661 ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Pancytopenia" ;
              rdfs:label "pancytopenia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#pantoprazole
:pantoprazole rdf:type owl:NamedIndividual ,
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A02BC02" ;
              rdfs:label "pantoprazole" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#paracetamol
:paracetamol rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N02BE01 " ;
             rdfs:label "paracetamol" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#paraneoplastic_syndrome
:paraneoplastic_syndrome rdf:type owl:NamedIndividual ,
                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10059420 ;
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Paraneoplastic syndrome" ;
                         rdfs:label "paraneoplastic syndrome" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#pentoxifylline
:pentoxifylline rdf:type owl:NamedIndividual ,
                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C04AD03" ;
                rdfs:label "pentoxifylline" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#peripheral_obliterating_arteriopathy
:peripheral_obliterating_arteriopathy rdf:type owl:NamedIndividual ,
                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10072121 ;
                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Peripheral obliterative arteriopathy" ;
                                      rdfs:label "peripheral obliterating arteriopathy" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#pneumonia
:pneumonia rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "J18.9" ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10035664 ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Pneumonia" ;
           rdfs:label "pneumonia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#pravastatin
:pravastatin rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C10AA03" ;
             rdfs:label "pravastatin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#prostatitis
:prostatitis rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "N41.0" ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10036978 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Prostatitis" ;
             rdfs:label "prostatitis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#pvSignal
:pvSignal rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Signal> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Free_text_reporting_element> :AKI_pathophysiology ,
                                                                                      :Discussion_and_Conclusion ,
                                                                                      :Reports_in_Vigibase ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_supported_by_individual_case_report> :Report1 ,
                                                                                                 :Report10 ,
                                                                                                 :Report11 ,
                                                                                                 :Report12 ,
                                                                                                 :Report13 ,
                                                                                                 :Report14 ,
                                                                                                 :Report15 ,
                                                                                                 :Report16 ,
                                                                                                 :Report2 ,
                                                                                                 :Report3 ,
                                                                                                 :Report4 ,
                                                                                                 :Report5 ,
                                                                                                 :Report6 ,
                                                                                                 :Report7 ,
                                                                                                 :Report8 ,
                                                                                                 :Report9 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_supported_by_statistical_entity> :CIForCiprofloxacinAndAKI ,
                                                                                             :CIForFluorquinolonesAndAKI ,
                                                                                             :CIForrenin-angiotensinSystemBlockersAndAKI ,
                                                                                             :CIForrenin-angiotensinSystemBlockersCombinedWithCiprofloxacinAndAKI ,
                                                                                             :OmeegaValueForEnalaprilAndAzithromycin ,
                                                                                             :Omega025ForEnalaprilAndAzithromycin ,
                                                                                             :Omega025ValueForCiprofloxacinAndEnalapril1 ,
                                                                                             :Omega025ValueForCiprofloxacinAndEnalapril2 ,
                                                                                             :Omega025ValueForCiprofloxacinAndLisinopril1 ,
                                                                                             :Omega025ValueForCiprofloxacinAndLisinopril2 ,
                                                                                             :Omega025ValueForCiprofloxacinAndRamipril1 ,
                                                                                             :Omega025ValueForCiprofloxacinAndRamipril2 ,
                                                                                             :Omega025ValueForEnalaprilAndAmoxicillin1 ,
                                                                                             :Omega025ValueForEnalaprilAndAmoxicillin2 ,
                                                                                             :Omega025ValueForEnalaprilAndLevofloxacin1 ,
                                                                                             :Omega025ValueForEnalaprilAndLevofloxacin2 ,
                                                                                             :OmegaValueForCiprofloxacinAndEnalapril1 ,
                                                                                             :OmegaValueForCiprofloxacinAndEnalapril2 ,
                                                                                             :OmegaValueForCiprofloxacinAndLisinopril1 ,
                                                                                             :OmegaValueForCiprofloxacinAndLisinopril2 ,
                                                                                             :OmegaValueForCiprofloxacinAndRamipril1 ,
                                                                                             :OmegaValueForCiprofloxacinAndRamipril2 ,
                                                                                             :OmegaValueForEnalaprilAndAmoxicillin1 ,
                                                                                             :OmegaValueForEnalaprilAndAmoxicillin2 ,
                                                                                             :OmegaValueForEnalaprilAndFlucloxacillin ,
                                                                                             :OmegaValueForEnalaprilAndLevofloxacin1 ,
                                                                                             :OmegaValueForEnalaprilAndLevofloxacin2 ,
                                                                                             :OverallReportsInVigibase ,
                                                                                             :RateRatioOfAcuteKidneyFailureWithCiprofloxacin ,
                                                                                             :RateRatioOfAcuteKidneyFailureWithCurrentFluoroquinoloneUse ,
                                                                                             :RateRatioOfAcuteKidneyFailureWithrenin-angiotensinSystemBlockers ,
                                                                                             :RateRatioOfAcuteKidneyFailureWithrenin-angiotensinSystemBlockersANDCiprofloxacin ,
                                                                                             :ReportsFromGermany ,
                                                                                             :ReportsFromItaly ,
                                                                                             :ReportsFromSpain ,
                                                                                             :ReportsFromSweden ,
                                                                                             :ReportsFromSwitzerland ,
                                                                                             :ReportsFromUnitedStates ,
                                                                                             :ReportsWithPositiveDechallenge ,
                                                                                             :Reports_with_CRF ,
                                                                                             :Reports_with_daily_dose ,
                                                                                             :Reports_with_daily_dose_for_enalapril ,
                                                                                             :Reports_with_indication ,
                                                                                             :Reports_with_oral_intake_form ,
                                                                                             :Reports_with_oral_intake_form_for_enalapril ,
                                                                                             :Reports_with_time_to_onset_info ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ,
                                                                         :enalapril ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug_drug_interaction> :ciprofloxacin_and_elalapril_interaction ;
          mp:supportedByData :Ciprofloxacin_and_enalapril_triggering_acute_kidney_injury ,
                             :ciprofloxacin_and_AKI ,
                             :ciprofloxacin_and_diarrhoea ,
                             :ciprofloxacin_and_other_ADRs ,
                             :key_reports ,
                             :lomaestro_review ,
                             :more_likely_alternative_reasons_for_AKI ,
                             :nested_case_control_study ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#initially_identified_on> "01/01/2018" ;
          rdfs:label "pv signal" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ramipril
:ramipril rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C09BX03" ;
          rdfs:label "ramipril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#ranitidine
:ranitidine rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A02BA02" ;
            rdfs:label "ranitidine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#rash
:rash rdf:type owl:NamedIndividual ,
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R21" ;
      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10037844 ;
      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Rash" ;
      rdfs:label "rash" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#renal_anaemia
:renal_anaemia rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10058123 ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Renal anaemia" ;
               rdfs:label "renal anaemia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#renal_failure
:renal_failure rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10038435 ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Renal failure" ;
               rdfs:label "renal failure" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#respiratoryInfection
:respiratoryInfection rdf:type owl:NamedIndividual ,
                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "J06.9 " ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10062352 ;
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Respiratory tract infection" ;
                      rdfs:label "respiratory infection" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#risperidone
:risperidone rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N05AX08 " ;
             rdfs:label "risperidone" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#rivaroxaban
:rivaroxaban rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "B01AF01 " ;
             rdfs:label "rivaroxaban" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#sepsis
:sepsis rdf:type owl:NamedIndividual ,
                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "A41.9 " ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10040047 ;
        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Sepsis" ;
        rdfs:label "sepsis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#septic_arthritis
:septic_arthritis rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10040057 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Septic arthritis" ;
                  rdfs:label "septic arthritis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#simvastatin
:simvastatin rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C10AA01" ;
             rdfs:label "simvastatin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#sitagliptin
:sitagliptin rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "A10BH01" ;
             rdfs:label "sitagliptin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#speechAndWalkingProblems
:speechAndWalkingProblems rdf:type owl:NamedIndividual ,
                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R47.9" ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10041466 ;
                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Speech disorder" ;
                          rdfs:label "speech problems" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#summary
:summary rdf:type owl:NamedIndividual ,
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Summary> ;
         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "A case series of 16 reports in VigiBase, the WHO global database of individual case safety reports, of acute kidney injury (AKI) associated with enalapril and ciprofloxacin as co-suspect or interacting medicines was identified through statistical screening for suspected drug interactions. The suspected interaction is unlabeled . Use of enalapril, an angiotensin converting enzyme (ACE) inhibitor, may lead to renal impairment due to altered renal haemodynamics in particular clinical situations or with other medicines that affect renal glomerular filtration. Increased serum creatinine and blood urea nitrogen have been observed in ciprofloxacin users and AKI has been reported in approximately 1 in 1,500 patients. Clinical assessment of the VigiBase reports identified 11 patients for whom a direct renal effect of ciprofloxacin alone or interacting with enalapril was the most likely explanation for AKI. In the remaining five reports an alternative explanation was more likely. Most of the patients in the 11 reports that supported causality had characteristics that increased their risk of renal failure, including patients aged over 80 years with two or more risk factors for ACE inhibitor-related renal failure. Despite their high risk most patients did not develop AKI until ciprofloxacin was added to their regime. A nested case-control study in a cohort of older male patients admitted to hospital for AKI demonstrated a 2-fold greater risk for AKI with fluoroquinolones compared with no use and a 4.6-fold increase in risk for fluoroquinolones combined with renin-angiotensin blockers. This observation is in keeping with the VigiBase disproportionality measure for ciprofloxacin and enalapril. The observed versus expected values for AKI with two other ACE inhibitors and ciprofloxacin as co-suspect or interacting also supported an ACE inhibitor class effect. There were insufficient reports to assess other fluoroquinolones. Although the mechanism is unclear, three observations support this signal. The two statistical observations from the published case-control study and from VigiBase and, thirdly, the onset of AKI after ciprofloxacin was added to the regimes of patients taking enalapril most of whom were already at high risk of AKI. This signal suggests further investigation is needed to ascertain if there is an additional risk of nephrotoxicity with ciprofloxacin in patients taking an ACE inhibitor." .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#tachycardia
:tachycardia rdf:type owl:NamedIndividual ,
                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R00.0" ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10043071 ;
             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Tachycardia" ;
             rdfs:label "tachycardia" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#tachypnoea
:tachypnoea rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R06.82" ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10043089 ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Tachypnoea" ;
            rdfs:label "tachypnoea" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#telavancin
:telavancin rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J01XA03 " ;
            rdfs:label "telavancin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#thiazide_diuretics
:thiazide_diuretics rdf:type owl:NamedIndividual ,
                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#DrugClass> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C03A" ;
                    rdfs:label "thiazide diuretics" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#time_to_onset_info
:time_to_onset_info rdf:type owl:NamedIndividual ,
                             <http://www.w3.org/2006/time#DurationDescription> ;
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_content> "The time to onset of AKI from commencement of ciprofloxacin, recorded for 13 patients, was 0 to 43 days with a median of 5.5 days. Most patients had taken ciprofloxacin for two weeks or less." ;
                    rdfs:label "time to onset info" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#tiotropium
:tiotropium rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "R03BB04" ;
            rdfs:label "tiotropium" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#torasemide
:torasemide rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C03CA04" ;
            rdfs:label "torasemide" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#triazolam
:triazolam rdf:type owl:NamedIndividual ,
                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "N05CD05" ;
           rdfs:label "triazolam" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#trimetazidine
:trimetazidine rdf:type owl:NamedIndividual ,
                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "C01EB15" ;
               rdfs:label "trimetazidine" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#trouble_with_knee
:trouble_with_knee rdf:type owl:NamedIndividual ,
                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "M25.569" ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10049032 ;
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Knee injury" ;
                   rdfs:label "trouble with knee" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#tubulo-interstitialNephritis
:tubulo-interstitialNephritis rdf:type owl:NamedIndividual ,
                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> " N12" ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10048302 ;
                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> """Tubulointerstitial nephritis
""" ;
                              rdfs:label "tubulo-interstitial nephritis" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#type2DiabetesMellitus
:type2DiabetesMellitus rdf:type owl:NamedIndividual ,
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ,
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Past_Diagnosis> ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "E11.9" ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10067585 ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "	Type 2 diabetes mellitus" ;
                       rdfs:label "type 2 diabetes mellitus" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#urinaryTractInfection
:urinaryTractInfection rdf:type owl:NamedIndividual ,
                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Indication> ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "N39.0" ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10046571 ;
                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Urinary tract infection" ;
                       rdfs:label "urinary tract infection" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#vancomycin
:vancomycin rdf:type owl:NamedIndividual ,
                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J01XA01" ;
            rdfs:label "vancomycin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#vomiting
:vomiting rdf:type owl:NamedIndividual ,
                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R11.10 " ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10047700 ;
          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Vomiting" ;
          rdfs:label "vomiting" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#walking_problems
:walking_problems rdf:type owl:NamedIndividual ,
                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R26.2" ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10017577 ;
                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Gait disturbance" ;
                  rdfs:label "walking problems" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#1000_mg_dosage
<http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#1000_mg_dosage> rdf:type owl:NamedIndividual ,
                                                                                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                                                                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                                                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                                                                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
                                                                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 1000 ;
                                                                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "1000 mg" ;
                                                                                                            rdfs:label "1000 mg dosage for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#2.5_mg_dosage
<http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#2.5_mg_dosage> rdf:type owl:NamedIndividual ,
                                                                                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                                                                                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                                                                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
                                                                                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 2.5 ;
                                                                                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "2.5 mg" ;
                                                                                                           rdfs:label "2.5 mg dosage for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#20_mg_dosage
<http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#20_mg_dosage> rdf:type owl:NamedIndividual ,
                                                                                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                                                                                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                                                                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
                                                                                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 20 ;
                                                                                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "20 mg" ;
                                                                                                          rdfs:label "20 mg dosage for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#50_mg_dosage_for_enalapril
<http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#50_mg_dosage_for_enalapril> rdf:type owl:NamedIndividual ,
                                                                                                                                 <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                                                                                                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :enalapril ;
                                                                                                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
                                                                                                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 50 ;
                                                                                                                        <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "50 mg" ;
                                                                                                                        rdfs:label "50 mg dosage for enalapril" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#500_mg_dosage
<http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#500_mg_dosage> rdf:type owl:NamedIndividual ,
                                                                                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Dosage> ;
                                                                                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ;
                                                                                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_interval_between_administrations> :one_day_interval ;
                                                                                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_dosage_unit> "mg" ;
                                                                                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 500 ;
                                                                                                           <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_dose_value> "500 mg" ;
                                                                                                           rdfs:label "500 mg dosage for ciprofloxacin" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Ciprofloxacin,_enalapril_and_acute_kidney_injury:_strengthening_of_a_drug_interaction_signal
<http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Ciprofloxacin,_enalapril_and_acute_kidney_injury:_strengthening_of_a_drug_interaction_signal> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Pharmacovigilance_Signal_Report> ;
                                                                                                                                                                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_author> :Dr_Ruth_Savage ;
                                                                                                                                                                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_signal> :pvSignal ;
                                                                                                                                                                                          mp:publishedBy :Uppsala_Monitoring_Centre ;
                                                                                                                                                                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_creation_date> "01/01/2018"^^xsd:date ;
                                                                                                                                                                                          <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_overall_conclusion> "causal association probable" ;
                                                                                                                                                                                          rdfs:label "Ciprofloxacin, enalapril and acute kidney injury: strengthening of a drug interaction signal" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report9Onsetforamoxicillin/clavulanate
<http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report9Onsetforamoxicillin/clavulanate> rdf:type owl:NamedIndividual ,
                                                                                                                                             <http://www.w3.org/2006/time#DurationDescription> ;
                                                                                                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#amoxicillin/clavulanate> ;
                                                                                                                                    <http://www.w3.org/2006/time#nominalPosition> "days" ;
                                                                                                                                    <http://www.w3.org/2006/time#numericPosition> 4 ;
                                                                                                                                    rdfs:label "Onset 9 for amoxicillin/clavulanate" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report9RouteOfAdministrationofamoxicillin/clavulanate
<http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report9RouteOfAdministrationofamoxicillin/clavulanate> rdf:type owl:NamedIndividual ,
                                                                                                                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Intake_Form> ;
                                                                                                                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#amoxicillin/clavulanate> ;
                                                                                                                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_form_of_intake> "oral" ;
                                                                                                                                                   rdfs:label "Route of administration of amoxicillin/clavulanate for report 9" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#UMC_measure_of_disproportionate_reporting_for_ciprofloxacin,_enalapril_and_AKI_(Ω)
<http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#UMC_measure_of_disproportionate_reporting_for_ciprofloxacin,_enalapril_and_AKI_(Ω)> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Disproportionality_Analysis_Measure> ;
                                                                                                                                                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_adverse_effect> :acuteKidneyInjury ;
                                                                                                                                                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ,
                                                                                                                                                                                                                                               :enalapril ;
                                                                                                                                                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 2.38 ;
                                                                                                                                                                                <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                                                                                                                                                                rdfs:label "UMC measure of disproportionate reporting for ciprofloxacin, enalapril and AKI (Ω)" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#UMC_measure_of_disproportionate_reporting_for_ciprofloxacin,_enalapril_and_AKI_(Ω025)
<http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#UMC_measure_of_disproportionate_reporting_for_ciprofloxacin,_enalapril_and_AKI_(Ω025)> rdf:type owl:NamedIndividual ,
                                                                                                                                                                                            <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Disproportionality_Analysis_Measure> ;
                                                                                                                                                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> :ciprofloxacin ,
                                                                                                                                                                                                                                                  :enalapril ;
                                                                                                                                                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_value> 1.56 ;
                                                                                                                                                                                   <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_database> "WHO Vigibase" ;
                                                                                                                                                                                   rdfs:label "UMC measure of disproportionate reporting for ciprofloxacin, enalapril and AKI (Ω025)" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_9_for_amoxicillin/__clavulanate
<http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Usage_for_report_9_for_amoxicillin/__clavulanate> rdf:type owl:NamedIndividual ,
                                                                                                                                                       <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug_Usage> ;
                                                                                                                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#concerns_indication_for_use> :respiratoryInfection ;
                                                                                                                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#is_related_with_drug_intake> <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#Report9RouteOfAdministrationofamoxicillin/clavulanate> ;
                                                                                                                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#refers_to_drug> <http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#amoxicillin/clavulanate> ;
                                                                                                                                              rdfs:label "Usage for report 9 for amoxicillin/ clavulanate" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#amoxicillin/clavulanate
<http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#amoxicillin/clavulanate> rdf:type owl:NamedIndividual ,
                                                                                                                              <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                                                                                                                     <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "J01CR02 " ;
                                                                                                                     rdfs:label "amoxicillin / clavulanate" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#fluticasone/salmeterol
<http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#fluticasone/salmeterol> rdf:type owl:NamedIndividual ,
                                                                                                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Drug> ;
                                                                                                                    <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ATC_code> "R03AK06" ;
                                                                                                                    rdfs:label "fluticasone/salmeterol" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#lyell'sSyndrome
<http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#lyell'sSyndrome> rdf:type owl:NamedIndividual ,
                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                                                                                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "L51.2" ;
                                                                                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10025166 ;
                                                                                                             <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Lyell syndrome" ;
                                                                                                             rdfs:label "Lyell syndrome" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#serumCreatinine300mmol/L
<http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#serumCreatinine300mmol/L> rdf:type owl:NamedIndividual ,
                                                                                                                               <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R79.89" ;
                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10011368 ;
                                                                                                                      <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Creatinine increased" ;
                                                                                                                      rdfs:label "serum creatinine 300 mmol/L" .


###  http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#serum_creatinine_501_mmol/L
<http://purl.org/OpenPVSignal/Signals/2018_1_iprofloxacin_enalapril_acute_kidney_injury.owl#serum_creatinine_501_mmol/L> rdf:type owl:NamedIndividual ,
                                                                                                                                  <http://purl.org/OpenPVSignal/OpenPVSignal.owl#Adverse_Effect> ;
                                                                                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_ICD_code> "R79.89" ;
                                                                                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_code> 10011368 ;
                                                                                                                         <http://purl.org/OpenPVSignal/OpenPVSignal.owl#has_MedDRA_prefered_term> "Creatinine increased" ;
                                                                                                                         rdfs:label "serum creatinine 501 mmol/L" .


#################################################################
#    Annotations
#################################################################

:introduction rdfs:label "introduction" .


:summary rdfs:label "summary" .


###  Generated by the OWL API (version 4.5.9.2019-02-01T07:24:44Z) https://github.com/owlcs/owlapi
